The effectiveness of a home-based, patient-specific, functional exercise program on patients with inclusion body myositis (IBM) by Johnson, Liam
Edith Cowan University 
Research Online 
Theses : Honours Theses 
2006 
The effectiveness of a home-based, patient-specific, functional 
exercise program on patients with inclusion body myositis (IBM) 
Liam Johnson 
Edith Cowan University 
Follow this and additional works at: https://ro.ecu.edu.au/theses_hons 
 Part of the Exercise Science Commons 
Recommended Citation 
Johnson, L. (2006). The effectiveness of a home-based, patient-specific, functional exercise program on 
patients with inclusion body myositis (IBM). https://ro.ecu.edu.au/theses_hons/1081 
This Thesis is posted at Research Online. 
https://ro.ecu.edu.au/theses_hons/1081 
Edith Cowan University 
  
Copyright Warning 
  
 
  
You may print or download ONE copy of this document for the purpose 
of your own research or study. 
 
The University does not authorize you to copy, communicate or 
otherwise make available electronically to any other person any 
copyright material contained on this site. 
 
You are reminded of the following: 
 
 Copyright owners are entitled to take legal action against persons 
who infringe their copyright. 
 
 A reproduction of material that is protected by copyright may be a 
copyright infringement. Where the reproduction of such material is 
done without attribution of authorship, with false attribution of 
authorship or the authorship is treated in a derogatory manner, 
this may be a breach of the author’s moral rights contained in Part 
IX of the Copyright Act 1968 (Cth). 
 
 Courts have the power to impose a wide range of civil and criminal 
sanctions for infringement of copyright, infringement of moral 
rights and other offences under the Copyright Act 1968 (Cth). 
Higher penalties may apply, and higher damages may be awarded, 
for offences and infringements involving the conversion of material 
into digital or electronic form.
USE OF THESIS 
 
 
The Use of Thesis statement is not included in this version of the thesis. 
Edith Cowan University 
School of Exercise, Biomedical and Health Sciences 
Bachelor of Science (Sports Science) Honours 
The Effectiveness of a Home-Based, 
Patient-Specific, Functional Exercise 
Program on Patients with Inclusion 
Body Myositis (IBM) 
Student: Liam Johnson 
Supervisor: Dr Dylan Edwards 
Date of Submission: 07 - 11 - 2006 
ABSTRACT 
Previous research has shown exercise to be beneficial in the treatment of 
myositis-affected patients. However, the potential of functional exercises to improve 
muscle strength and function in the absence of disease progression markers in 
patient's with Inclusion Body Myositis (IBM) is not well understood. It is believed 
that the initial exercise dose and patient specificity is of paramount importance in the 
successful use of this modality in the routine :inanagement and long term treatment of 
such patients. The objective of this study was to investigate the effects of a home-
based, patient-specific functional exercise programme, including aerobic exercise and 
resistance training, on muscle strength, endurance and function, and the aerobic 
capacity of the patient. 
Pre muscle strength and functional assessments, and a maximal aerobic 
exercise test were conducted on seven IBM patients' prior to a 12-week training 
period. As part of the patient's routine management, the patients maintained their 
scheduled visits to the neuromuscular clinic whereby their serum creatine kinase (CK) 
levels were assessed pre- and post-training intervention. The patients' were gently 
and selectively overloaded in the early stages of their 12-week exercise program to 
encourage compliance and gradual adaptation, and to prevent 'overtraining' early in 
the program. The exercise program combined upper and lower body resistance 
training exercises with an aerobic component. 
It was anticipated that the patients would exercise frequently at low intensities 
and at volumes that would optimally induce muscular strength and endurance 
improvements. Integral to the prescription of exercise for this patient group was the 
patient-specificity of the exercise dose being prescribed and the method of exercise 
overload. The patient's progress was monitored by fortnightly phone calls; 
maintenance of the patients scheduled visits to their specialist at the neuromuscular 
clinic, and a 'training diary' was given to the patient to fill out daily. At the 
conclusion of the training intervention period, all parameters of muscle strength and 
function were reassessed, and the patients undertook follow-up testing of their 
maximal aerobic capacity. 
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The results show that, a diseased muscle, having undergone exercise training, 
maintained its strength (knee extension [100.9±10%]) (mean±standard error [SE]), 
whilst significant improvements (p < 0.05) were observed in otherwise healthy, 
trained muscles, with hip abduction strength improving by 59.1±31 %, shoulder 
abduction strength increasing by 66.1±12% and hip flexion strength increasing by 
83.7±35%. Functional assessments showed that there was not a statistically 
significant improvement in the time taken to perform a stair climb and walk 30 
metres, and also the amount of paces used during the walk. However, the patient 
group improved in all functional tasks. 
Research suggests that muscle strength and function can be improved by 
resistance training and an aerobic exercise program. However, further research is 
required to evaluate the effects of a mild, daily, exercise program performed in the 
patient's home. Exercise guidelines for this clinical population are substantially 
lacking. However, this study has added to the current depth of knowledge regarding 
exercise and Inclusion Body Myositis patients'. Program adherence, exercise 
prescription and progression and program monitoring are areas which require further 
examination in long-term, multi-centre exercise intervention trials. It would appear 
that an exercise program tailored to the individual is important for the clinical 
management ofthe disease. 
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1. Introduction 
Inclusion Body Myositis (IBM) is an idiopathic inflammatory myopathy (liM) 
that is characterized by progressive muscle weakness and reduced muscle strength, 
endurance and function (Alexanderson & Lundberg, 2005; Mastaglia, Garlepp & 
Phillips, 2003). It is the most common inflammatory myopathy amongst adults over 
50 years of age and is more common in men than women (Felice, Relva & Conway, 
1998; Ranque-Francois, Maisonobe, Dion, Piette, Chauveheid, Amoura & Papo, 
2005; Sivakumar & Dalakas, 1997; Vogel, 1998). Prominent clinical findings include 
asymmetric weakness in both distal and proximal muscle groups, in particular the 
quadriceps femoris muscles and wrist and finger flexors (Amato, Gronseth, Jackson, 
Wolfe, Katz, Bryan & Barohn, 1996; Arnardottir, Alexanderson, Lundberg & Borg, 
2002; Felice, Relva & Conway, 1998; Lotz, Engel, Nishino, Stevens & Litchy, 1989). 
In patients with IBM, serum creatine kinase is often elevated, whilst 
histological findings include rimmed vacuoles, endomysia! inflammation, beta-
amyloid accumulation and atrophic fibres (Arnardottir, et al., 2002; Spector, Lemmer, 
Koffman, Fleisher, Feuerstein, Hurley & Dalakas, 1997). The rate of progression of 
IBM is relatively slow compared to other forms of liM, with muscle weakness 
developing insidiously (Felice, Relva & Conway, 1998; Lotz, Engel, Nishino, Stevens 
& Litchy, 1989; Mastaglia, Garlepp, Phillips & Zilkd, 2003). This can result in a 
diagnosis not being made for several years after the patient initially complains of 
symptoms (Phillips, Zilko & Mastaglia, 2000). 
The pattern of muscle weakness in IBM patients is primarily the early atrophy 
of the quadriceps femoris muscle, which often leads to the patient falling due to their 
'knees buckling' or the patient tripping over an obstacle due to their inability to raise 
their foot to the height they perceive they are raising it to safely clear the obstacle. 
The initial presentation is often due to the patient having experienced a fall or near-
fall which the patient has difficulty explaining or justifying why it occurred 
(Mastaglia, et al., 2003). The selective pattern of muscle involvement in IBM patients 
can result in the clinical diagnosis of the disease (Mastaglia, et al., 2003). However, a 
muscle biopsy is . commonly used and is thought to be the definitive diagnostic 
process, enabling not only a diagnosis to be made, but it can also indicate the severity 
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of the disease in it's current state and confinn the actual form of myositis that is 
affecting the patient (Mastaglia, et al., 2003). The use of magnetic resonance imaging 
(MRI) can assist in the confirmation of a diagnosis, in particular if a muscle biopsy is 
inconclusive or when atypical muscle involvement is prevalent (Mastaglia, et al., 
2003). 
Corticosteroids and immunosuppressive agents are generally accepted as the 
medical treatment for patients with IBM, but even short-term benefits from using 
these are rare (Isenberg, Allen, Farewell, Ehrenstein, Hanna, Lundberg, Oddis, 
Pilkington, Plotz, Scott, Vencovsky, Cooper, Rider & Miller, 2004; Mastaglia, 2000). 
Immunoglobulin therapy has been shown to elicit a mild improvement and possibly 
slow the disease progression (Amato, Barohn, Jackson, Pappert, Schenk & Kissel, 
1994; Dalakas, Sonies, Dambrosia, Sekul, Cupler & Sivakumar, 1997; Soueidan & 
Dalakas, 1993). A typical characteristic of IBM is its resistance to the commonly 
accepted forms of immunotherapy (Amato et al., 1996; Oldfors & Lindberg, 1999). 
It was previously thought that physical exercise should be avoided due to the 
concern that it would enhance the inflammatory process (Alexanderson & Lundberg, 
2005; Dalakas, 1989; Jones, Newham, Round & Tolfree, 1986). However, studies 
have shown physical training of patients with polymyositis (PM) and dermatomyositis 
(DM) resulted in muscle strength improvements in the absence of an inflammatory 
reaction (Alexanderson, Stenstrom & Lundberg, 1999; Wiesinger, Quittan, Aringer, 
Seeber, Volc-Platzer, Smolen & Graninger, 1998A; Wiesinger, Quittan, Graninger, 
Seeber, Ebenbichler, Sturm, Kerschan, Smolen & Graninger, 1998B). Exercise 
training programs targeting improvements in muscular strength should include 
isotonic, isometric and isokinetic exercises (Aitkens, McCory, Kilmer & Bernauer, 
1993; Mastaglia, et al., 2003). 
Falling due to lower body weakness and the increased risk of cardiovascular 
disease due to reduced mobility are significant health issues that often lead to 
disability and a decreased quality of life in IBM patients. Exercise programs can 
result in strength gains, prevent strength loss and can be performed without muscular 
fatigue or inflammation in IBM patients (Amardottir, et al., 2002; Spector, et al., 
·1997). Physical activity has been shown to be a safe and appropriate enablement 
8 
strategy in other inflammatory myopathies. Exercise has been shown to improve a 
patient's muscular strength and endurance, and importantly, can improve the patient's 
well being (Wiesinger, et al., 1998A). There is evidence to suggest exercise could 
potentially play an important role in the delaying of the disease progression, with an 
investigation into the pattern of muscle weakness in IBM patients presenting 
relatively novel findings (Felice, Relva & Conway, 1998). It was found that 
weakness and muscle atrophy in the forearms was particularly more profound on the 
non-dominant side of the body. The investigators in this study suggested that daily, 
functional activities such as washing, buttoning and writing delay the atrophy and 
progressive weakness associated with this muscle disease, and therefore concluded 
that performing exercise may result in a delaying of the disease progression (Felice, 
Relva & Conway, 1998). 
The purpose of this study is to investigate the effectiveness of a functional, 
home-based, patient-specific exercise program on muscle strength, endurance and 
function in an IBM patient group. The potential of functional exercises to improve 
muscle strength and function in the absence of disease progression markers is not well 
understood. It is believed that an exercise program tailored to the individual is 
important for the routine management and long-term treatment of the disease. 
Integral to this study is the correct prescription of both resistive and aerobic 
exercise, in particular the type and amount of the chosen exercises, and the 
individuality of the exercise programs to be given to these patients. In undertaking 
this study, it was believed that an aggressive exercise program will result in either 
non-compliance in the program or excessive muscle fatigue/soreness leading to 
withdrawal from the study. Consequently, the patient specific exercise programs that 
were prescribed to the IBM patients were initially very conservative to account for 
these important issues and to ensure the technical aspects of the exercises are learnt so 
that the patient employed the correct technique and applied the adequate loading onto 
their muscles. 
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2. Literature Review 
2.1 Idiopathic Inflammatory Myopathies 
Idiopathic Inflammatory Myopathies (liM) is a diverse group of disorders with 
various clinical and pathological presentations that are typically characterised by 
muscle weakness and chronic muscle inflammation (Oddis, Rider, Reed, Ruperto, 
Brunner, Koneru, Feldman, Giannini & Miller, 2005; Phillips & Mastaglia, 2000). 
Mastaglia, Phillips and Zilko (1997) report the cause of some liM's to be "identifiable 
viral, bacterial, fungal, or parasitic micro-organisms". They can be localised and 
restricted to a single muscle, or extensive and involve a range of skeletal muscles 
(Mastaglia, · et al., 2003). Three common forms of liM's are polymyositis (PM), 
dermatomyositis (DM) and inclusion body myositis (IBM), and each has distinctive 
clinical, histological and pathological manifestations (Bohan & Peter, 1975; cited in 
Isenberg, et al., 2004; Mastaglia, et al., 2003). Idiopathic inflammatory myopathies 
are immune-mediated myopathies which can occur in isolation, in conjunction with 
other autoimmune disorders or with connective tissue disorders (Mastaglia, et al., 
2003). 
2.2 Inclusion Body Myositis 
Originally developed in 1971 (Yunis & Samaha, 1971; cited in Tawil & 
Griggs, 2002), the term 'inclusion body myositis' was applied to an idiopathic 
inflammatory myopathy variant clinically and pathologically different to other known 
myopathies. Yunis and Samaha (1971; cited in Derk, Vivino, Kenyon & Mandel, 
2003) used it to describe a patient with abnormal tubular filaments found within 
muscle fibres on electron microscopy. It was further elaborated on in 1978 by 
Carpenter, Karpati, Heller and Eisen (1978; cited in Derk, et al., 2003) who found 
distinguishing features to dissociate it from polymyositis and dermatomyositis. 
'Inclusion' refers to the inclusion bodies found in the prominently affected muscle 
cells, whilst 'myositis' is an acknowledgement of the inflammation that is found in 
the involved muscles. 
IBM is the most·common inflammatory myopathy in individuals over the age 
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of 50, and is believed to be more common in males (Felice, Relva & Conway, 1998; 
Lotz, Engel, Nishino, Stevens & Litchy, 1989; Oldfors & Lindberg, 1999; Phillips, 
Zilko & Mastaglia, 2000). In a 10-year retrospective study on the prevalence of IBM 
in Western Australia, Phillips, Zilko and Mastaglia (2000) reported the prevalence of 
IBM to be 9.3 per million population in Western Australia (using population figures 
adjusted for sex, the gender differentiated figures were 10.9 and 7.7 for males and 
females respectively per million). Due to the diagnostic process, the time differential 
between the onset of symptoms and diagnosis, and the chronicity of the disorder, the 
authors acknowledge their figures to most likely be an underestimation and conclude 
that further population studies are required 
Ninety five IBM patients were identified in a study in The Netherlands, with 
43 males and 21 females comprising 'the subject population (31 were unable to 
complete the study for various reasons) (Badrising, Maat-Schieman, van 
Houwelingen, van Doom, van Engelen, Faber, Hoogendijk, de Jager, Koehler, de 
Visser, Verschuuren & Wintzen, 2005). Badrising, Maat-Schieman and van Duinen 
(2000) estimated the prevalence of IBM in.The Netherlands to be 4.9 per million 
population (the investigators thought this to be an underestimation though). However, 
in respect to the two described studies, different criterion was used to diagnose the 
IBM, which may affect the resultant prevalence figures. Worldwide figures of the 
prevalence of IBM are unknown, and certainly more research is required to 
systematically determine how common IBM is, and to account for other 
epidemiological aspects of the disease. 
2.3 Clinical Presentation 
A slowly progressive muscle disease of insidious onset, muscle weakness in 
IBM patients is typically selective, with initial atrophy and weakness found in the 
quadriceps femoris muscles in the lower limbs (Mastaglia, et al., 2003; Oldfors & 
Lindberg, 1999; Tawil & Griggs, 2002). The weakened knee extensors, and the falls 
they predispose the patient to, are often the initial presenting symptom of IBM 
(Mastaglia, et al., 2003). The forearm flexors are also selectively involved in the 
earliest stages of the disease progression, in particular the flexor digitorum profundus 
muscles, resulting iri a'n increasing difficulty in maintaining flexion of the distal 
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phalanges when the patient is performing a task requiring grip strength (Mastaglia, et 
al., 2003). 
Phillips, Cala, Thickbroom, Melsom, Zilko and Mastaglia (2001) suggest the 
involvement of the medial gastrocnemius is also typical of IBM. Finger extensors, 
thumb hyperextension and flexor digitorum sublimis gradually become involved, 
along with the more proximal muscles in the upper limbs (Mastaglia, et al., 2003). 
Difficulty swallowing has also been recorded by IBM patients due to the involvement 
of pharyngeal and oesophageal muscles (Badrising, et al., 2005; Mastaglia, et al., 
2003; Ranque-Francois, et al., 2005; Tawil & Griggs, 2002). 
Atypical patterns of muscle involvement are not rare, with a more proximal or 
asymmetric pattern of muscle involvement having been reported (Lindberg, Persson, 
Bjorkander & Oldfors, 1994). This is supported by a study by Phillips et al (2001) 
which concluded that the common pattern of muscle involvement is not always the 
case in IBM patients. Whilst it has been widely acknowledged as being the most 
common myopathy in individuals over the age of 50 (Ranque-Francois, et al., 2005; 
Sivakumar & Dalakas, 1997; Vogel, 199S), a study by Badrising et al (2005) reported 
the onset of symptoms to be generally after the age of 40 as a common characteristic. 
There is often a substantial time differential between the onset of symptoms and 
actual diagnosis, with Phillips, Zilko and Mastaglia (2000) reporting an average delay 
of 4.4 years. 
2.4 Etiology 
The etiology of IBM is largely unknown (Tawil & Griggs, 2002). Clinically, 
IBM has been linked to mild increases in other systemic autoimmune disorders and 
there is strong evidence to suggest it is an immune-related disease (Tawil & Griggs, 
2002). Mastaglia, Phillips and Zilko (1997) support this by claiming in IBM "cellular 
immune mechanisms have been directly implicated in causing the muscle fibre 
injury".' Cytotoxic CDS+ T-cells are prominent within endomysia! infiltrations, major 
histocompatibility complex (MHC) class 1 expression by muscle fibres, and the 
infiltration of non-necrotic fibres by CDS+ lymphocytes and macrophages are 
typically found atthe cellular level (Mastaglia, Phillips & Zilko, 1997; Mastaglia, et 
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al., 2003; Ranque-Francois, et al., 2005; Tawil & Griggs, 2002). 
The muscle tissue of an IBM patient exhibits pro-inflammatory cytokines 
interleukin-1 (IL-1a), interleukin H1 (IL-1/3), interferon-'¥, lymphotoxin and tumour 
necrosis factor (TNF -a) predominantly produced by macrophages and monocytes 
(Lundberg, 2000; Lundberg & Nyberg, 1998; Mastaglia, et al., 2003). These play 
important roles as up-regulating and down-regulating factors of molecules integral to 
the homing process of inflammatory cells to the tissue (Lundberg & Nyberg, 1998). 
Cytokines can perform functions such as T -cell activation, lymphocyte and 
mononuclear phagocyte recruitment, stimulation of expression of major 
histocompatibility complex molecules and potentially can directly damage target cells 
(Mastaglia,- et al., 2003). These functions can then aid in the generation or further 
enhancement of autoimmune responses and assist in the local inflammatory response 
(Mastaglia, et al., 2003). 
Inflammatory inhibiting cytokines, such as transforming growth factor-/3 and 
interleukin 4 (IL-4), have been found in idiopathic inflammatory myopathies 
(Lundberg, 2000). Chemotactic and inflammatory chemokines have also been 
observed in liM's, including monocyte chemoattractant protein-1 (MCP-1), 
macrophage inflammatory protein-1a (MIP-1a) and regulated-upon-activation normal 
T -cell expressed and secreted (RANTES) (Confalonieri, Bernasconi, Megna, Galbiati, 
Cornelio & Mantegazza, 2000; Lundberg, 2000; Mastaglia, et al., 2003). 
The presence of T -cell receptors in the incursive lymphocytes indicates a 
possible case of restrictive gene rearrangements, raising the prospect that the T -cell 
activation is due to a potential superantigen (Lindberg, Oldfors & Tarwoski, 1994; 
Tawil & Griggs, 2002). The persistence of this pattern throughout the disease 
progression implies that the primary antigenic stimulus continues to cause the 
immune-mediated muscle disease post-presentation of the initial symptoms (Tawil & 
Griggs, 2002). However, the absence of ~long term and complete responses to 
immunosuppressive agents indicates that there maybe more to the cause of IBM than 
the immune-mediated etiological belief (Tawil & Griggs, 2002). 
Abnormal. accumulation of proteins, including beta-amyloid, within the 
13 
vacuolated muscle fibres is commonly reported in IBM patients, however, it is unclear 
as to what initiates their deposition and whether or not they result from or cause the 
inflammatory process (Askanas & Engel, 2003; Derk, et al., 2003; Tawil & Griggs, 
2002). The relationship between these accumulated proteins and immune 
mechanisms prevalent in IBM patients is unknown (Mastaglia, Phillips & Zilko, 
1997). Evidence of nitric oxide induced oxidative stress, the contributions of genetics 
and the possibility of the overexpression of dB-crystallin in IBM patients further 
confounds the process of establishing a definitive etiology for this inflammatory 
myopathy (Alexanderson & Lundberg, 2005; Mastaglia, et al., 2003; Ranque-
Francois, et al., 2005; Tawil & Griggs, 2002). 
Early and accurate diagnosis is important to guide the treatment process and 
enable a definitive prognosis to be made as early as possible. This is particularly 
important when distinguishing the various forms of idiopathic inflammatory 
myopathies, as PM/DM often respond favourably to treatment, whilst IBM has been 
shown to be quite resistant to various therapeutic interventions (Mastaglia, et al., 
2003; Mastaglia, Phillips & Zilko, 1997; Ranque-Francois, et al., 2005). 
IBM patients have a selective pattern of muscle involvement of the quadriceps 
femoris muscles and the forearm flexors of the upper limbs (Phillips, et al., 2001). 
The greater susceptibility of some muscles to the muscle disease IBM is currently an 
unresolved issue. Phillips et al (2001) lists possible reasons for this selectivity, 
including muscle size differences, fibre-type proportions, physiological roles and 
functional reserve of different muscles, and the possibility of an accumulation of 
mutant DNA deletions that occur with ageing. This characteristic muscular selectivity 
can be more difficult to identify in the latter stages of the disease, and atypical 
patterns of muscle involvement and asymmetric weakness have been found 
(Mastaglia, Phillips & Zilko, 1997). The insidious onset of proximal and distal 
weakness in an individual over the age of 50 should raise initial suspicions of IBM 
(Ranque-Francois, et al., 2005) 
As a prominent .marker of muscle damage, elevated serum creatine kinase 
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(CK) has been used to support the diagnosis of IBM, however normal or slightly 
elevated levels of CK are typically found in IBM patients (Badrising, et al., 2005; 
Derk, et al., 2003; Mastaglia, Phillips & Zilko, 1997; Ranque-Francois, et al., 2005; 
Tawil & Griggs, 2002). The extent and severity of the myositis can be indicated by 
electromyography, but ultimately, a muscle biopsy is the most definitive standard in 
providing a conclusive confirmation of IBM (Derk, et al., 2003; Mastaglia, et al., 
2003; Mastaglia, Phillips & Zilko, 1997; Tawil & Griggs, 2002). A muscle biopsy 
should ideally be performed prior to the commencement of treatment and will not 
only allow confirmation of the diagnosis but will also provide an insight into the 
severity and extent of the muscle inflammation and exclude any other forms of 
myopathies {Mastaglia, Phillips & Zilko, 1997; Mastaglia, et al., 2003). 
An open biopsy is preferable, and using magnetic resonance imaging (MRI) to 
assist in selecting a biopsy site may prevent a potential sampling error that could 
possibly interfere with the identification of characteristic clinical features or if the 
clinical picture is not obvious (Mastaglia, et al., 2003; Oldfors & Lindberg, 1999). 
The muscle biopsy should identify a number of features, including endomysia! 
inflammation and invasion of non-necrotic fibres, rimmed vacuoles and intracellular 
amyloid deposits (Tawil & Griggs, 2002). The presence of these features provides a 
definite diagnosis of IBM, and other clinical and pathological criteria are not required. 
Griggs, Askanas, DiMauro, Engel, Karpati, Mendell & Rowland (1995) developed a 
distinct criteria to enable diagnosis that took into consideration typical biopsy findings 
to allow rapid diagnosis, and also other clinical and laboratory features (refer to 
Appendix B) that enable diagnosis despite possible atypical muscle involvement or 
the absence of the primary clinical diagnostic features (Refer to Appendix B for the 
diagnostic criteria of IBM) 
2.6 Treatment 
The treatment of Inclusion Body Myositis can be considered to currently be a 
work in progress (Arnardottir, et al., 2002; Ranque-Francois, et al., 2005). The 
unknown etiology of the disease presents clinicians with a challenging task in 
developing strategies or therapeutic measures to treat IBM. The current options 
· available to patients are all non-selective in relation to their impact on the immune 
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system (Mastaglia, et al., 2003; Mastaglia, 2000). It has been shown that the 
conventional method of pharmacological treatment prescribed to IBM patients often 
has little, if any effect, on the progression of the disease (Alexanderson & Lundberg, 
2005; Griggs & Rose, 1998). However, most IBM patients are initially placed on a 
course of medication, such as a corticosteroid (most commonly prednisone) and an 
immunosuppressive agent, such as methotrexate, to combat the disease to some 
degree, with the patient's responses to these drugs varying greatly (Mastaglia, 2000). 
Immunoglobulin therapy has been trialled previously, with findings to suggest 
it could play a role in the treatment of the muscle disease (Mastaglia, Phillips and 
Zilko, 1998; Soueidan & Dalakas, 1993). A slowing of the disease and possible 
moderate improvement has been reported in a number of short-term studies (Amato, 
Barohn, Jackson, Pappert, Sahenk & Kissel, 1994; Dalakas, et al., 1997; Soueidan & 
Dalakas, 1993; Walter, Lochmuler, Toepfer, Schlotter, Reilich, Schroder, Muller-
Felber & Pongratz, 2000). In a study by Mastaglia, Phillips and Zilko (1998), muscle 
myometry scores improved following intravenous immunoglobulin (IVIg) in some 
cases, however, only slight functional improvements were observed, and on the basis 
of this, it can be difficult to justify considering the expensive nature of the treatment 
(Mastaglia, Phillips & Zilko, 1998). 
Other forms of therapy have been proposed, including, L-camitine, coenzyme 
Q, antioxidants and testosterone, but are yet to be clinically assessed (Engel & 
Askanas, 1998). Despite the uncertainty regarding various drug therapies and their 
ultimate effect on IBM patients, these treatment modalities deserve further research in 
the form of multi-centre, long-term, randomized, placebo-controlled therapeutic trials 
(Mastaglia, 2000; Walter, et al., 2000). Exercise therapy has been trialled with some 
positive results for IBM patients in the absence of disease progression markers 
(Amardottir, et al., 2002; Spector, et al., 1997). 
2. 7 Exercise and IBM 
2. 7.1 Strength Training 
Strength training in otherwise healthy individuals is well established as a 
means of increasing muscle strength, endurance and size (Feigenbaum & Pollock, 
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1999), but it can also play an important role in the rehabilitation of patients with 
neuromuscular disorders (McCartney, Moroz, Garner, McHomas, 1988; Milner-
Brown & Miller, 1988; Spector, Gordon, Feuerstein, Sivakumar, Hurley & Dalakas, 
1996). Phillips and Mastaglia (2000) have demonstrated its benefits in the 
management ,of various myopathies; however, its presence in the long-term treatment 
and clinical management of inflammatory myopathy patients is not well understood. 
Further research is required in regards to the establishment of training protocols that 
will optimally induce muscle strength, endurance and functional changes, and the 
development of outcome measures that are suitably sensitive, and provide reliable and 
valid results in assessing the impact of exercise as a therapeutic means in 
neuromuscular disordered patient groups (Mastaglia, et al., 2003). The repetitive 
nature of resistance training should not prevent the patient's muscles from responding 
positively to the strength tasks (Taivassalo, De Stefano, Chen, Karpati, Arnold & 
Argov, 1999). 
Two key studies provide the current basis of knowledge in regards to the 
effect of an exercise training program on IBM patients. These investigations were 
warranted on the basis of positive findings from physical training in PM/DM patients 
and other myopathic patients. Wiesinger et al (1998A) found significant 
improvements in muscle strength, oxygen uptake and overall wellbeing. The six 
week training intervention also saw improvements in 'activities of daily living' 
(ADL) scores, whilst there was no significant increase in disease activity compared to 
the control sample. 
Wiesinger et al (1998B) reported a clinically significant increase in the aerobic 
capacity of the sample population. Peak oxygen uptake, peak isometric torque in the 
lower extremities and ADL scores all rose to significant levels in the absence of a rise 
in serum creatine phosphokinase (CPK). The six-month study included a combination 
of stationary cycling and step aerobics, as did the earlier study by Wiesinger et al 
(1998A). However, the duration of the 1998A study (6 weeks) and the sample size of 
the later study (1998B) (n=8) must be considered when analysing their results. 
Alexanderson, Stenstrom and Lundberg (1999) performed a study 
· investigating the . effects of a home exercise program on PM/DM patients, with 
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positive results reported. In accordance with the Functional Index (FI) scale, six of 
ten cases were found to have significantly improved muscle function in the absence of 
a rise in CPK. Tre remaining four patients all reported functional improvements. 
Muscle biopsies and MRI' s were also used to confirm the safety of the exercise 
program in terms of monitoring potential muscle inflammation as a result of the 
exercises performed. 
The Short Form-36 (SF-36), which is a widely used assessment tool in 
inflammatory myopathy studies (Isenberg, et al., 2004), was used to assess changes in 
health and wellbeing, and significant improvements in health status were found as a 
result of the exercise program. Various other investigations have been performed to 
assess the· impact of exercise, in particular strength-training programs, on patients 
with myopathies (Phillips & Mastaglia, 2000). Despite the small sample sizes that are 
prevalent in the majority of these studies, muscle strength improvements are typically 
seen as a result of various exercise protocols and training periods. 
An investigation into the asymmetrical patterns of muscle weakness and 
atrophy observed in IBM patients suggests that exercise may potentially delay the 
progression of the muscle disease (Felice, Relva & Conway, 1998). The study found 
the non-dominant forearm flexor was significantly more atrophied and weaker than 
the dominant forearm flexor. From this, the investigators concluded that dominant 
side, daily activities, such as writing, washing and buttoning, delay the progression of 
the disease, and evidence of less pronounced atrophy in other groups that rarely 
perform unilateral exercises support this conclusion (Felice, Relva & Conway, 1998). 
The investigators recommend the prescription of moderate resistant exercise, in 
particular targeting the weakened forearm flexors and quadriceps muscles, and 
acknowledge the need for further studies in this area (Felice, Relva & Conway, 1998). 
Spector et al (1997), conducted a 12-week progressive resistance strength-
training program, primarily designed to target the predominantly weakened muscles 
in 5 IBM patients. The exercise program was prescribed with upper and lower 
extremity exercises alternated between exercise sessions to minimize fatigue, and 
suitable recovery . periods, and volumes and intensities of workload were chosen. 
These 'training' variables were prescribed on the basis of previous resistance training 
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studies in a Post-Polio Muscular Atrophy patient group, in which dynamic muscle 
strength increased following a 1 0-week progressive resistance strength training 
program (Spector, Gordon, Feuerstein, Sivakumar, Hurley & Dalakas, 1996). 
The investigators also minimised the eccentric phase of the chosen activities. 
Resistance training exercises cause damage to the muscle, but in an otherwise healthy 
population, neural adaptation and muscle hypertrophy occur as a result of this, and the 
muscles repair and regrow to become larger and stronger (Sale, 1988). Eccentric 
exercises damage the muscle and can disrupt the muscle cell membrane, as evidenced 
by the release of serum CK from the damaged fibres (Jones, Newham, Round & 
Tolfree, 1986), an increase in cytokines in the muscle (Fielding, Manfredi, Wenjing, 
Fiatiarone, Evans & Cannon, 1993) and local inflammation (Fielding, et al., 1993; 
Luthi, Howald, Claasen, Rosier, Vock & Hoppeler, 1986). Concentric exercises 
minimise this muscle damage whilst still being beneficial to the patient, such that 
muscle strength and size gains typically occur (Hurley, Redmond, Pratley, Trueth, 
Rogers & Goldberg, 1995). In this study, the concentric phase of the prescribed 
resistance exercises was a particular focus. Strength assessments, fatigue and 
activities of daily living scales, MRI's and muscle biopsies to analyse the 
immunochemistry and histopathological changes, and markers of muscle damage 
were used as assessment tools to quantify the effect of the training program. It was 
concluded from this study that IBM patients are able to safely participate in regular 
resistance training in the absence of excessive muscle fatigue, immunological and 
histological abnormalities, and strength gains, in particular in the least weak muscles, 
can be expected. 
Arnardottir et al (2002) investigated the effect of exercise on IBM patients 
with their study on the effects of a home-based exercise program on muscle function 
and it's implications for the inflammatory response by the muscle. Seven IBM 
patients were subject to a 12-week, 5 days-a-week exercise program designed to be 
implemented in the patients home. Easy and moderate exercise programs were 
prescribed to the patients based upon their Functional Index (FI) score, and they 
included both resistive exercises, mobility exercises and a stretching routine. The 
study also included an aerobic component, with the patients instructed to take a 15-
minute self-paced walk 5 days a week. The prescription of exercises and the 
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associated training variables was based upon work done on a PM/DM training study 
which resulted in positive muscle function effects being observed following the 
intervention (Alexanderson, Stenstrom & Lundberg, 1999). 
In Arnardottir's et al (2002) investigation, the exercise program was shown to 
be a safe treatment option with muscle inflammation and the histopathology of the 
disease remaining stable throughout the intervention period. Whilst there was an 
absence of significant strength gains across all parameters tested, the program was 
well tolerated by the group and there was not a reduction in muscle strength whilst the 
patients underwent the exercise training. The investigators acknowledged 
experimental deficiencies and the relatively low intensity of the prescribed exercise 
program niay have contributed to the lack of significant data. However, this study 
provides further evidence of the delaying capacity exercise may have on the 
progression of the disease. 
The small sample size's in both studies, the duration of the training periods, 
and the absence of statistically significant improvements in muscle function and 
strength measures, reductions in fatigue and increases in ADL scores suggests further 
research is required before conclusive statements regarding the effect of exercise on 
IBM patients can be made. This is acknowledged by both Spector et al (1997) and 
Arnardottir et al (2002). However, from their studies it can be concluded that exercise 
can be safely tolerated by IBM patients and can be confidently prescribed in the 
knowledge it will not lead to a decrease in muscle strength as a result of the training 
program. 
These studies highlight the need for the development of standardised training 
protocols that will lead to optimal gains in muscle strength, endurance and functional 
improvements which will, importantly, translate to a higher quality of life and provide 
the patients with a greater capacity to perform ADL's. For exercise as an evidence-
based, therapeutic intervention to be established and integrated into the daily lives of 
IBM patients, further research is required. Patient-centred, resistance training 
protocols, sensitive and reliable outcome measures and disease-specific health status 
measures for idiopathic inflammatory myopathy patient groups are areas which 
·should be of particular interest in future studies. 
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2. 7. 2 Aerobic Exercise 
The health benefits derived from aerobic exercise are numerous and far-
reaching and have been well established, with 30 minutes or more per day the 
prescribed amount for disease prevention and the promotion of good health in healthy 
individuals (Pate, Pratt, Blair, Haskell, Macera, Bouchard, Buchner, Ettinger, Health 
& King, 1995; Pollock, Gaesser, Butcher, Despres, Dishman, Franklin & Garber, 
1998). Adaptations in the heart and skeletal muscle systems, disease prevention, 
improved respiratory function and overall well-being highlight the importance of 
exercise for all individuals, including patients with inflammatory myopathies 
(Mastaglia, et al., 2003; Taivassalo & Haller, 2005). Taivassalo et al (1999) 
demonstrated aerobic exercise training can elicit benefits in nonmetabolic myopathies 
and mitochondrial myopathies, with significant improvements found in estimated 
aerobic capacity, heart rate and blood lactate at submaximal exercise intensities. A 
lifestyle change and appropriate physical therapy habits should be the aim in the 
prescription of an exercise program designed to attain maximum benefit whilst 
minimising the risk to the participant (Pollock, et al., 1998). 
These findings are supported by Taivassalo, Shoubridge, Chen, Eng, 
Kennaway, Phil, DiMauro, Arnold and Haller (2001) and Taivassalo and Haller 
(2005). However, as Taivassalo and Haller (2005) and Taivassalo et al (1999) have 
stated in regards to patients with mitochondrial myopathies and other various 
neuromuscular disorders, exercise intolerance can be a prominent manifestation of the 
muscle disease and the reduced activity level of the IBM patient. Characterised by 
fatigue at low exertion levels, weakness of active muscles and lactic acidosis, the 
resultant deconditioning and increased functional limitations not only further 
emphasises the individual's sedentary lifestyle, but also increases the risk of disease 
(Taivassalo & Haller, 2005; Trenell, Sue, Kemp, Sachinwalla & Thompson, 2006). 
The muscle weakness, reduced endurance and increased fatigue which tend to 
dominate the lives of patients with inflammatory myopathies are impairments which 
negatively affect the patient's quality of life, independence and general health and 
well-being (Phillips & Mastaglia, 2000). The reduction in aerobic capacity results in 
the patient's mobility. being severely affected and subsequently cardiac and 
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respiratory function is impaired, putting the patients at an increased risk of 
cardiovascular disease (Alexanderson & Lundberg, 2005; Hebert, Byrnes, Baethage, 
Wolf & Kinasewitz, 1990). 
Wiesinger, Quittan, Nuhr, Volc-Platzer, Ebenbichler, Zehetgruber and 
Graninger (2000) reported PM/DM patients to have reduced peak oxygen uptake 
values compared to age and sex-matched controls. It was concluded from this study 
that a number of factors possibly contribute to why PM/DM patients are aerobically 
impaired; including the sedentary lifestyle the disease tends to impart upon the 
patient, cardiac involvement, pulmonary involvement or muscle atrophy or 
inflammation as a result of the disease. Whilst further clarification is required to 
determine the primary cause of their reduced aerobic capacity, it was shown that a 
carefully constructed, exercise testing regimen can be safely used to determine the 
aerobic capacity of myositis patients. 
Wiesinger et al (1998B) reported an aerobic capacity increase following their 
physical training program in PM/DM patients. Using a patient-specific cycling 
protocol, the patients combined this with a step aerobics exercise session to develop 
their aerobic capacity. The use of the cycling protocol to aerobically train the patients 
was justified by the investigators on account of the concentric exercises causing less 
muscle damage than eccentric exercise (this is when the active muscle is lengthened). 
(Wiesinger, et al., 1998B). The patient's aerobic capacity was increased by 28%, 
which was a significant improvement. A 9% reduction in resting heart rate was also 
found, whilst the ventilatory threshold of the patients was increased by 8%, which 
was another statistically significant result. 
Hicks, Drinkard, Summers and Rider (2002) found similar findings in their 
study into the effects of aerobic exercise in juvenile DM patients. Taivassalo et al 
(1999) demonstrated an aerobic exercise program can provide physiological and 
functional benefits in the absence of disease progression markers in chronic myopathy 
patients·. Taivassalo et al (1999) reported positive adaptations from a patient-specific 
training program that was prescribed at low intensities, but acknowledged the long-
term effects of an .aerobic exercise program was yet to be established. Exercise as a 
therapeutic intervention· has been shown to improve balance in the elderly, and with 
22 
falling a major risk factor in IBM patients, improvements in balance that will reduce 
the risk of falling is desirable (Barnett, Smith, Lord, Williams & Baumand, 2003). 
Numerous other studies have been conducted in assessing the impact of an 
aerobic training program on patients with various forms of myopathies, with generally 
positive results having been found. Aerobic capacity, maximum V02 consumption 
and exercise tolerance has been demonstrated to improve to significant levels 
following an aerobic exercise program (Phillips & Mastaglia, 2000). Phillips and 
Mastaglia (2000) question the relative importance of the duration of the training 
period, stating that there may not be any additional benefit of implementing a longer 
training period (>24-weeks) in comparison to a short-term program (>6-weeks). 
Rather, the intensity of the exercise may have a greater influence on the resultant 
aerobic capacity changes. To date, there is an absence of information regarding the 
effect of aerobic exercise training on IBM patients. 
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3. Materials & Method 
3.1 Study design 
3.1.1 Patients 
Seven Patients (2 women and 5 men, mean age 66. 7±6.2 years) with IBM 
were recruited from the Australian Neuromuscular Research Institute at Sir Charles 
Gardiner Hospital, Perth, Western Australia. Diagnosis was confirmed by clinical and 
histological findings, and all have been in a state of progressive decline in muscle 
strength and function, and overall functional ability, for 5-9 years. This study had 
ethical approval from Sir Charles Gardiner Hospital and Edith Cowan University, and 
the each patient signed an informed consent prior to the beginning of this study (refer 
to Appendix C). 
3.1.2 Experimental Design 
Clinical examination, muscle strength and function assessments, and a 
maximal aerobic exercise test were conducted prior to a 12-week exercise training 
intervention. Serum CK levels were assesse,d pre- and post-training intervention as 
part of the patients' routine management. A Penny and Giles Transducer hand-held 
myometer (refer to Appendix F) was used to ascertain the patients muscle strength in 
the following movements bilaterally: shoulder abduction/external rotation, elbow 
flexion/extension, wrist extension, hip abduction/flexion, and knee flexion/extension. 
As per Figure 1, trained/untrained movements were tested pre and post intervention in 
diseased and healthy muscles. Grip strength was also measured using a Spiedel and 
Keller, Stabil 3 grip dynamometer. Functional tasks evaluated were walking 30 
meters unaided, walking up one flight of stairs (11 steps) (Refer to Appendix D for 
muscle assessment recording worksheet and Appendix E for strength assessment 
positions for hand-held myometry). Standard instructions and levels of positive 
reinforcement were implemented throughout the testing occasions for each patient, 
pre- and post-training intervention. 
The patients were also required to fill out the SF-36 instrument to ascertain 
potential changes in the patients overall health status as a result of the intervention 
(refer to Appendix G fot· a sample SF-36). Each patient undertook a maximal aerobic 
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exercise test on a stationary bike, with the Metamax 3B portable V02 system utilised 
to assess their aerobic capacity. Each patient undertook a familiarisation session prior 
to the initial test, whereby the patient was prepared with a standard 5-lead ECG and 
equipped with the Metamax 3B system harness. Resting heart rate (RHR) (beats per 
minute [bpm]) and blood lactate levels (taken via the fingertip) was taken from the 
patient, whilst the Borg 0 - 10 Rating of Perceived Exertion (RPE) scale (Borg, 
1982), which was to be used at one minute intervals during the test to monitor the 
patient's exertion levels, was explained to the patient. The patient was advised to 
cease the test if they felt unwell for any reason, and this was reinforced by the 
supervising Doctor who attended the test to ensure a safe test was being conducted 
and no undue stress was being placed on the patient. 
Due the variability in the aerobic capacity of each patient within the patient 
group, the protocol for the aerobic exercise testing was individualised based on the 
patients' familiarisation tests, but only with regards to the wattage amount the patients 
were to increase every two minutes. Common to the entire patient group was the 
initial starting load of 20 Watts (W), the timing of the incremental increases in 
wattage (every two minutes of the test), and the maintenance of a cycling cadence 
between 40 and 50 revolutions per minute (RPM). The testing protocol was based on 
similar research previously applied in inflammatory populations (Jeppesen, Olsen & 
Vissing, 2003; Trenell, et al., 2006) and preliminary tests completed by a number of 
the IBM patient's. V02 (ml/kg/min-1) peak, heart rate (bpm), blood lactate (mmor1) 
and RPE were recorded for analysis and cardiac rhythm was monitored during the test 
for safety purposes by the trained Doctor in attendance. The tests were performed in 
the cardio-pulmonary department of Sir Charles Gardiner Hospital, administered by a 
trained Honours student and a laboratory technician. 
3.1.3 Training Program 
Each patient undertook a home-based, patient-specific 12-week exercise 
program integrating stretching exercises, resistance exercises and an aerobic 
component. The patients' were very gently overloaded in the early stages of the 
program to encourage compliance and gradual adaptation, and to prevent 
'overtraining' in the initial stages of the program. The total amount of exercise 
prescribed per week, which will be referred to as the training load, comprised the 
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number of repeated sets, duration of recovery period between exercises, and number 
of exercises per week. To begin with, the load prescribed was very light in order to 
assess the patients tolerance to the tasks assigned, ensure the correct techniques and 
movements were employed and to monitor the patients' compliance to the overall 
program. 
The patients were presented with an exercise booklet (refer to Appendix H), 
containing illustrations and exercise descriptions, which entailed the range of 
stretches and exercises the patient could potentially perform during the intervention 
period. Exercises were selected that emphasised patient function, and so where 
possible, multi-joint exercises were preferentially used as opposed to single-joint and 
movements were performed in functional positions involving balance and stabilizing 
aspects. Where functional and body weight exercises were considered too difficult, 
isometric, single joint muscle contractions were performed (American College of 
Sports Medicine, 2003, p.243). 
A range of stretches was prescribed on the basis of increasing joint mobility 
and improving the patients' muscular flexibility, with particular attention paid to the 
wrist and finger flexors and extensors which are prominent areas of weakness and 
exhibit a reduced range of motion in this clinical population. The patients were given 
approximately 6-8 different stretches to perform, with 2-3 sets to be performed of 
each exercise and for either 10-15 breaths, or a specific number of repetitions as 
assigned by the investigator. Counting by number of breaths was encouraged to avoid 
the patients holding their breaths, which can occur during resistance training 
exercises, particularly when performing isometric exercises in older trainees (Fleck & 
Kraemer, 2004, p.21). Exercise selection was patient-specific and prescribed based 
upon observation of the patient's ability to perform certain movements and areas of 
reduced joint range ofmotion. The patient's were instructed to perform their selected 
stretches once daily. 
The resistance exercises were selected on an individual basis and were also 
prescribed upon observation of the patients' ability to perform various functional 
movements. Exercises were selected or modified such that between 8-15 repetitions 
could be . performed; then two repetitions less than the maximum number of 
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repetitions the patient could perform during the initial assessment was prescribed. 
The exercise program was separated into upper and lower extremity components, with 
approximately 3 exercises performed 2-3 times each (separated by 3-4 minutes rest), 
once daily, 3 times per week. With the aerobic component of the patients exercise 
program to be performed 3 times per week, the patients were encouraged to perform 
the resistance exercises and the aerobic training on separate days. Accordingly, the 
patients were to perform the upper and lower extremity exercises on the same day, but 
to avoid overloading the patient's, the two components of the resistance exercises 
were to be performed separately, with one component to be trained in the morning, 
and then one later in the day. This was to prevent overtraining and enable the patient 
to recovery between tasks. The patients were also instructed to have one day of rest 
each week. A study by Kilmer, Wright and Aitkens (2005) on the impact of a home-
based physical activity and dietary intervention in people with neuromuscular diseases 
supports this conservative approach. 
The exercises the patients were to perform were initially demonstrated to 
them, and then performed by the patient themselves under supervision to ensure the 
correct techniques and movements were being employed. This also allowed the 
investigator to evaluate the patients' current levels of muscular strength, endurance 
and function and to prescribe exercise volume and frequency that would slightly 
challenge the patient, but would also be achievable. Specifically, mild increments in 
training load were scheduled fortnightly, although modified according to patient 
tolerance and compliance. Patients were instructed that if the exercise became 'easy' 
during a given two week period, they could increase the number of repetitions by a 
maximum of four, for each exercise. The scheduled load increments did not increase 
all variables simultaneously, but one variable in a given fortnight, and in the 
following order: exercise number (increased to ~4-6 exercises), then number of 
repetitions (15 maximum), and lastly, number of sets (maximum of 3). The patients 
were also asked to contact the investigator to inform them of any program changes 
when they occurred. 
The aerobic component of the training program involved the patients cycling 
on a Monark Ergomedic 894E stationary cycle ergometer at an intensity 
corresponding to 80% ·of their maximum heart rate achieved during thdr maximal 
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aerobic test (Taivassalo, De Stefano, Argov, Matthews, Chen, Karpati & Arnold, 
1998). Polar A3 Heart rate monitors to enable the patients to exercise at the 
prescribed intensity were borrowed by the patients from the Edith Cowan University 
Sports Science Department for the duration of the training period. Volume and 
frequency of this component of the patients exercise programs was individually 
assessed and administered in consultation with Senior Physicians at the Hospital. The 
patients were instructed to cycle 3 times per week, and progression of the patients' 
aerobic training component was achieved in much the same way as the resistance 
training component of their exercise program. If the patient felt the cycling became 
too 'easy', they were instructed to increase the duration for which they were cycling 
at, with a maximum increase of 2 minutes for any fortnightly period. This subscribes 
to the basic aim of this program, which was to have the patients exercising at greater 
frequencies and lower intensities to induce optimal strength and functional gains 
(American College of Sports Medicine, 2000, p.145). 
3.1.4 Program Monitoring 
This consisted of fortnightly phone calls; the patients' maintaining their 
scheduled visits to their specialist at the clinic, and a 'training diary' was given to the 
patient to fill out daily. A diary template (refer to Appendix I) was provided for the 
patient to record certain training information and subjective feelings related to their 
training performance. This included daily recordings of exercise data, such as the 
specific exercises undertaken by the patient and the training load they subscribed to. 
The investigator also asked the patients' to record in their diaries subjective feelings 
of fatigue, soreness and breathlessness immediately following the completion of the 
daily exercises, and also each morning of each day. These ratings were based on a 1 
to 10 visual analogue scale, with '1' being 'no fatigue, soreness or breathlessness at 
all' and ' 10' representing 'extreme fatigue, soreness or breathlessness'. The patients 
were also asked to provide a rating of perceived exertion (RPE) of each exercise 
session they completed, which was based on the Borg 0-10 scale (Borg, 1982), 
immediately following the conclusion of each session. Any incidence of falls or near 
falls, and why, was to be recorded by the patients, and they were encouraged to 
provide any other information they felt necessary to disclose that may have impacted 
on their ability to perform the exercise program. Presentation of the training program 
was conducted through· a home-visit by the investigator. At the conclusion of the 
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training intervention period, all parameters of muscle strength and function were 
reassessed, and the patients also undertook follow-up testing of their maximal aerobic 
capacity. 
3.2 Data Analysis 
Muscle strength and function was compared pre and post a 12-week exercise 
training intervention and analysed in both group and individual data sets. Pre and 
post data was averaged and tested for normality using the Kolmogorov Smimov test 
before a paired two sample t-test was applied for each subject and muscle action. For 
each subject, the post-intervention score was normalised to pre-intervention values, 
averaged across all subjects and represented by means and standard error (±SE). The 
exercise program included the training' of both diseased and non-diseased muscles, 
and the investigation used both within-subject and within-study controls to evaluate 
the effect the exercise program had on the various muscle groups tested. The lack of 
compliance to the exercise program by two of the patient group resulted in an 
additional analysis being utilized in this study. Thus, a comparison between the 
compliant (n=5) and non-compliant (n=2) patient groups (compliance defined as 
adhering to the exercise program and performing the prescribed exercises for greater 
than 70% of the training period) evolved during this study. 
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4. Results 
Mean group data normalised to pre-training levels shows that the diseased 
muscle in the absence of training experienced a decrease in strength levels, as shown 
by the 19.6±10% (mean±SE) decline in grip strength (Figure 1). Yet, the healthy, 
untrained muscle (shoulder external rotation) experienced maintenance, or in this 
case, a slight increase in strength (4.2±6%). With training however, the diseased 
muscle, having undergone exercise training, maintained its strength (knee extension 
[100.9±10%]), whilst significant improvements (p < 0.05) were observed in otherwise 
healthy, trained muscles, with hip abduction strength improving by 59 .1±31 %, 
shoulder abduction strength increasing by 66.1±12% and hip flexion strength 
increasing by 83.7±35%. 
A comparison between the compliant (n=5) and non-compliant (n=2) patient 
groups that evolved during this study shows the substantial difference the training 
intervention had on the patients muscle strength (Figure 2). Normalised to pre-
training levels, the compliant patient group experienced a mean increase in muscle 
strength across all trained muscles tested of 38.4±12%, and there was a significant 
difference (p < 0.05) in improvement when compared to the non-compliant subset of 
patients. The non-compliant group that trained infrequently showed an overall mean 
increase in muscle strength of 12.2±9%. 
Table 1 presents a breakdown of the compliant patients mean muscle strength 
data pre and post training, accounting for a sample of a number of distinct subsets of 
muscles tested, including diseased and otherwise healthy muscles, and, trained and 
untrained muscles. This table shows the respective one and two-tailed p-values for 
the sampled muscles. The two-tailed p-values were assigned to the muscle subsets 
that cannot be hypothesized as increasing in strength as a result of the exercise 
training due to either the muscles being diseased or untrained. Whereas, the 
healthy/trained muscles were assessed by one-tailed p-values in support of the 
hypothesis that an otherwise health muscle should increase in strength following a 
period of exercise training. It can be observed from the table that shoulder abduction, 
hip flexion, hip abduction and knee flexion all resulted in significant improvements 
·by the group. 
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In assessing the impact of the exercise intervention on a single, compliant 
patient, there was a significant difference (p < 0.05) between mean pre and post scores 
for all trained muscles (Figure 3a). The patient improved from an average of 5.9±0.6 
Kg-fpre-training to 7.3±0.8 Kg-fpost-training. The mean change in muscle strength 
for all muscle's involved in training following the exercise intervention of a single, 
non-compliant patient is shown in Figure 3b, and it can be seen that the patient 
experienced a mild decrease in muscle strength having not completed the exercise 
training. The patients muscle strength averaged 12.7±1.2 Kg-f post intervention, 
slightly lower than the mean muscle strength pre-intervention (13.2±1.3 Kg-f). 
Group stair climb and walk time/pace number data are presented in Table 2. It 
can be seen from this table that whilst there was not a statistically significant 
improvement in any of the functional tasks, on average, the patient group improved in 
all tasks. It can be seen that the patients developed a larger amplitude gait as 
indicated by the reduction in the number of paces used to complete the 30m walk. 
The sample size used in this study should be considered as possibly a contributing 
factor that affected the power of the statistical analysis. 
The functional improvements of a single compliant patient are illustrated in 
Figure 4, with the patient's time taken to complete both the stair climb and 30m walk 
reduced following the exercise training period. The patient completed the post-
intervention stair climb in 39 seconds, an improvement of over 64% on their pre-
training effort (64 seconds). Additionally, the patient reduced their walk time by over 
95%, with a post-training walk time of 64 seconds compared to a pre-training time of 
125 seconds. 
The functional deficits experienced by a single, non-compliant patient, as 
shown in Figure 5, with time taken to walk 30m and perform a stair climb increased 
following the exercise program. The patient's time to climb the 11 steps of the stair 
climb increased from 19 seconds to 22 seconds, just over a 13% increase in time 
taken. There was an increase in time taken to perform the 30m walk also, with the 
patient completing the task in 50 seconds post-intervention compared to 31 seconds 
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the patient took pre-intervention, an increase by over 61% in time taken to perform 
the task. 
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Fig. 1. Mean group data (±SE) of compliant patients (n=5) normalised to 
pre-training, showing that in the absence of training, a diseased muscle 
experiences a mild strength loss, while a healthy untrained muscle does 
not. Yet with training, a diseased muscle can maintain its strength and 
other non-diseased muscles can experience a substantial improvement in 
strength. 
* p < 0.05 
** p < 0.001 
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Fig.2. Mean group data (±SE), including diseased and 
healthy muscles that were involved in the training, normalised 
to pre training. There is a significantly greater muscle strength 
improvement of trained muscles for the compliant patient 
group when compared to the non-compliant patients' 
(p < 0.05). 
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Table.1. Trained group (n=7) mean (±SE) muscle strength data pre and post exercise 
intervention, where P(T <=t) one-tail was used for any healthy/trained muscles, and 
P(T<=t) two-tail for any diseased/trained or untrained and healthy/untrained muscles. 
* p < 0.05 
** p < 0.001 
Shoulder Abduction 
Hip Abduction · 
~::;~~Knee Flexion 
Mean±SE P-value 
Pre Post 
194.57±49.99 182.85±55.32 0.099 
8.60±1.46 8.08±1.46 0.435 
9.96±1.49 9.00±1.16 0.161 
6.77±0.57 6.83±0.48 0.910 
7.34±0.96 6.68±0.99 0.125 
10.09±1.19 10.28±0.72 0.384 
10.25±1.07 16.79±1.68 **0.0005 
9.57±0.92 15.09±1.41 *0.008 
7.65±1.13 10.17±0.88 *0.009 
9.75±1.09 10.56±1.08 *0.02 
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Fig.3a). Mean individual data (±SE) of changes in muscle 
strength of all trained muscles of a single, compliant patient. 
Fig.3b). In the same muscle groups of a non-compliant 
patient over this time period, muscle strength remains 
unchanged. 
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Group (n=7) mean (±SE) functional task data, showing the mean time taken 
(seconds) pre and post intervention to perform a stair climb and 30 metre walk, and also 
the number of paces used by the patient during the walking task. 
Functional Task Mean±SE P-value 
Pre Post 
Stair Climb 19.4±10.7 15.2±6.1 0.214 
30m Walk 43.4±20.4 29.8±8.8 0.160 
Paces during 30m walk 67.0±20.0 52.8±7.2 0.170 
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Fig.4. Mean (±SE) individual functional capacity data of a single, compliant 
participant. 
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Fig.5. Mean (±SE) individual functional capacity data of a single, non-
compliant participant following the exercise intervention. 
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5. Discussion 
The present study has shown that a 12-week home-based, patient-specific 
functional exercise program performed by the IBM patient, can lead to significant 
strength gains in muscles not affected by the disease, the maintenance of strength in 
diseased muscle groups and improvements in the performance of functional tasks in 
the absence of muscle damage. Figure 1 illustrates the positive impact an exercise 
program can have on an IBM patient's muscle strength if they adhere to the training 
program as prescribed. Strength training can result in an increase in strength in 
healthy muscles, and can delay the loss of strength in diseased muscles, whilst 
functional improvements, despite not reaching statistical significance, could 
potentially be viewed as clinically significant improvements for the positive effect 
these improvements have on the day-to-day functioning of the patients in this study. 
It has been previously thought that exercise programs should be avoided by 
patients with inflammatory myopathies due to the concern that the exercise may 
enhance the inflammatory process (Alexanderson & Lundberg, 2005; Dalakas, 1989; 
Jones, et al., 1986). However, studies in other forms of idiopathic inflammatory 
myopathies showed a positive response to physical training in the absence of an 
adverse inflammatory reaction (Alexanderson, Stenstrom & Lundberg, 1999; 
Wiesinger, et al., 1998A; Wiesinger, et al., 1998B). Furthermore, studies with IBM 
patients using strength training and aerobic exercise as part of the patient's treatment 
concluded that exercise can be performed by the IBM patient safely and can lead to 
dynamic strength improvements and possibly prevent loss of muscle strength 
(i\rnadottir, et al., 2002; Spector, et al., 1997). 
Optimal exercise guidelines resulting in improvements in muscle strength and 
function have not been established in either a home-based or laboratory setting. The 
emphasis this study placed on the improvement of patient function by having the 
patients perform exercises specifically designed to improve function, including the 
use of multi-joint exercises and the integration ofbalance and stabilizing components 
to the exercises, distinguishes this study from previous exercise intervention studies in 
this clinical population. The training program in this investigation was also quite 
novel in that it included the training of both diseased and non-diseased muscles, and 
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uses within-subjects and within-study controls to assess the impact strength training 
had on these various muscle groups. 
From subjective interviews with the patients, it was noted that previously these 
patients received physical therapy that was too strenuous and resulted in exacerbated 
muscle pain and further muscular weakness. However, this study has shown that 
carefully considered exercise load prescription can result in the attainment of 
functional benefits and strength gains. The conservative approach this study has 
taken supports a study by Kilmer, Wright and Aitkens (2005). A pilot study 
undertaken prior to the commencement of the present study identified program 
adherence and excessive muscle fatigue/soreness leading to possible non-compliance 
and/or withdrawal from the study as potential challenges this study would encounter. 
The pilot study performed on a group of IBM patients (including a number of 
patients in this study) provided an insight into the compliance of the patients to 
perform their exercise program at home when not under the direct supervision of the 
investigator to be a limiting factor in strength and functional improvements. In the 
present study, compliance was defined as adhering to the program and undertaking 
the exercises as prescribed for greater than 70% of the intervention period. The 
diaries given to the patients to record their daily activities in, and the regular 
patient/investigator contact via the telephone, was expected to minimise the degree of 
non-compliance and to provide the impetus for the patient to maintain a detailed 
record of what they were actually performing in their exercise sessions. Positive 
reinforcement from the investigator and the patients' partners and the maintenance of 
the patients' scheduled visits to the Neuromuscular clinic are other measures that were 
put in place to ensure program adherence. However, upon post-intervention 
interviews, two of the group were assessed as being non-compliant, having not 
completed the majority of the exercise program as instructed. For various reasons, 
both subjects exercised infrequently and applied a training load not specified by the 
investigator. As a result of this, the results of this study have at times been analysed 
as two separate entities; a compliant group and a non-compliant group. 
The selective pattern of muscle involvement that characterises IBM patients 
ensured that the exercise program had varying effects on the muscle groups tested in 
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this study. The significant increases in muscle strength observed in four of the 
trained/healthy muscles tested indicates the importance of strength training in this 
patient group, as whilst these muscle are not directly involved in the disease, they play 
important roles in the patients capacity to perform daily, functional activities. The 
maintenance of strength through training of an involved muscle is another important 
finding. When analysed in light of the mild strength loss in the untrained/diseased 
muscle (grip strength), this clearly suggests 'Strength training can delay the loss of 
muscle strength in muscles typically involved in IBM, thus supporting findings 
reported by Spector et al (1997). 
The progressive nature of IBM results in the gradual deterioration of strength 
m the muscles selectively involved in this disease. This must be taken into 
consideration when analysing the effect of a strength training exercise program on the 
diseased muscle groups. A definitive rate of decline in strength is unknown in this 
pathological group; however, a study by Rose, McDermott, Thornton, Palenski, 
Martens and Griggs (2001) found a mean decline in muscle strength of 4% from 
baseline in IBM patients over a six month period. Lindberg, Persson, Bjorkander and 
Oldfors (1994) reported a 1.4% loss of strength from baseline per month. The loss of 
strength in IBM patients' is likely to vary between individuals and the stage of disease 
progression they are at (Dawes, Korpershoek, Freebody, Elsworth, van Tintelen, 
Wade, Izadi & Jones, 2006). It can be seen from Figure 1 that untrained/diseased 
muscle groups can experience a noticeable decrement in strength over a 12-week 
period. 
The variability in the degree of weakness and level of endurance between 
different IBM patients, and their general level of fitness makes it necessary to design 
exercise programs that are specific to each patient. The patient-specific aspect of this 
study allowed the investigator to overload each patient in consideration of the 
progression of the disease and the muscle selectivity that characterises IBM. It also 
enables the investigator to integrate the exercise program into the patients' homes 
with greater ease by allowing for greater flexibility in the prescription of exercises in 
consideration of the availability of space and resources that are present in each 
patient's home. 
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The involvement of the wrist and finger flexors in this muscle disease affects 
the force output of the patients hand and wrist, causing them to have reduced grip 
strength. At the completion of the exercise intervention, the compliant patients in this 
study exhibited an average decline in muscle strength of 19.6%. This is despite the 
fact that the wrist and finger flexors were involved in the performance of other 
exercises prescribed to the patients, such as bicep curls. For the entire patient group, 
grip strength decreased on average by almost 8% (Table 3 -refer to Appendix N). 
The importance of grip strength in the performance of everyday activities should not 
be understated, it is required in simple, menial tasks such as hanging out the washing, 
drying dishes and serving food, thus the implications of having a reduced grip 
strength, that is declining continuously, are serious and a limiting factor in the 
patient's ability to independently function. 
The decline in grip strength should be kept in mind when examining the effect 
of the exercise program on other muscles primarily involved in this disease, but which 
were trained in this study. Grip strength can be viewed as a within-subject control for 
diseased/trained or untrained muscles, thus the maintenance of strength as shown by 
the knee extensors of the compliant patients is particularly promising. The knee 
extensors have been shown to maintain their strength over the intervention period and 
knee extensor exercises were a major part of the exercise program. The prominent 
atrophy and weakness of the quadriceps muscles indicates the extent of damage this 
muscle group experiences as a result of the disease (Amato, Gronseth, Jackson, 
Wolfe, Katz, Bryan & Barohn, 1996; Arnardottir, Alexanderson, Lundberg & Borg, 
2002; Felice, Relva & Conway, 1998) (refer to Appendix L for pictures of a patient in 
this study). 
The serious consequences this has, as being a core reason as to why this 
patient group experiences falls frequently, validates the place of knee extension 
exercises in any exercise program to be prescribed in this patient group. Using sit-to-
stand exercises, which have important functional applications, to improve the patients 
muscle· strength in the knee extensors, the compliant patients averaged a 0.9% 
improvement in strength. Whilst only a small improvement, this supports findings by 
Spector et al (1997), who found muscle groups with the lowest Medical Research 
Council (MRC) ratings· pre-training showed the least amount of improvement post-
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training. 
However, Table 3 shows the average knee extensor strength pre-training to be 
7.32 Kg-f, whilst post-training, the patients averaged 6.66 Kg-f of the total patient 
group. This is a 10% loss in strength over the 12-week intervention period. This is 
obviously offset by the inclusion of non-compliant patients in the data used to 
calculate these figures, which further emphasizes the importance of the exercise 
program, and the potential benefits that can be derived, by the patients by exercising 
the diseased muscle groups. The maintenance of strength in the knee extensors has 
implications in the patients capacity to perform functional tasks such as a 30m walk 
and a stair climb, with knee extensor strength a key factor in the ability of the patients 
to perform these functional tasks, and in particular the ability to climb stairs. 
Shoulder external rotation, a healthy/untrained muscle group, was used as a 
'control' in this study to establish strong evidence that supports the effect of the 
strength training on healthy/trained muscles. It forms a within-subject control 
variable to show that by not adhering to the exercise program, there will effectively be 
no net change in muscle strength of an untrained/healthy muscle at the completion of 
the intervention period. The collected data of the compliant patients shows they 
increased their strength in this muscle by 4.2%, whilst the patient group as a whole, 
increased in strength by just over 2% (7.45 Kg-fpre-training compared to 7.64 Kg-f 
post-training) (refer to Table 3). The slight increase in strength may be a secondary 
effect of the patients exercising the shoulder muscles involved in shoulder external 
rotation in the performance of other exercises directed at improving other muscle 
actions, such as shoulder abduction. Greater movement at the shoulder joint would 
also be expected to have resulted from the patient having undertaken shoulder 
strengthening exercises and upper limb stretching movements to enable a more 
flexible movement pattern, thus potentially encouraging a greater force production. 
Figure 1 shows the statistically significant improvements in shoulder 
abduction as a result of the strength training program the IBM patients performed. As 
expected, the healthy/trained muscles that perform the shoulder abduction muscle 
action responded well to the training, with the compliant patients shoulder abduction 
strength improving by ·over 66%. The improvements seen here support previous 
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evidence of the benefits that can be derived by using an isometric contraction to target 
a particular area (Skelton & Dinan, 1999). The gain in muscle strength achieved in 
the shoulder abductors has important applications in the performance of activities of 
daily living. Daily chores such as hanging out the washing to dry and washing the 
dishes, require upper limb muscle strength, and the inability to perform these tasks 
due to a lack of strength reduces the independency of these patients, which negatively 
impacts on the patient's ability to care for themselves. Thus, the importance of 
strengthening a non-diseased muscle cannot be understated, for its valuable 
contribution to undertaking the most basic, functional tasks should be recognized. 
The statistically significant improvement in hip abduction strength in a 
healthy/trained muscle in this study has important implications for the daily 
functioning and general health and well:.being of this patient group. A 59% increase 
in hip abduction strength was found in the compliant patient group, whilst statistical 
significance was also found when comparing pre and post muscle strength scores of 
the total patient group (Table 3). Hip abduction strength has practical applications as 
a key factor in balance and stabilizing tasks. The lower limbs abduction muscles are 
vital during walking to maintain the body's weight over the limb that is in contact 
with the ground. Hip abduction strength is also a necessary tool for stabilizing tasks, 
which is particularly useful in this patient group that is prone to falls. Developing 
strength in this area is advantageous to the patient as a balance strategy to resist 
falling or correcting displacement. Postural control and improved gait are other 
functional benefits derived from a lower limb strength training exercise program 
(Campbell, Robertson, Gardner, Norton, Tilyard & Buchner, 1997; Simpson, 
Harrington & Marsh, 1998). 
In addition to hip abduction strength, hip flexor strength is another vital 
component of an exercise program that aims to primarily improve the functional 
capacity of this patient group by improving the patients muscular strength, endurance 
and function. Hip flexor strengthening has been shown to play an important role in 
developing greater postural control and improving the gait of the elderly, and in 
particular those that are more susceptible to falls, which is prominent in IBM patients 
due to their weakened quadriceps (Campbell, et al., 1997; Simpson, Harrington & 
Marsh, 1998; Skeltoti & Dinan, 1999). IBM patients tend to develop abnormal gait 
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patterns due to lower limb wealmess, resulting in either increased risk of falling, or 
reduced mobility as a consequence of a fear of falling (Lord, Lloyd & Li, 1996). By 
improving hip flexor strength, it is anticipated the patients will be less susceptible to 
falls and experience improved dynamic stability when trained in combination with 
other lower limbs, which will have a follow-on effect on the patients' confidence to 
be more mobile, which in tum has numerous secondary health benefits for the patients 
(Kannus, Sievanen, Palvanen, Jarvinen & Parkkari, 2005; Lord, Ward & Williams, 
1996). 
In the compliant subset of patients, hip flexor strength significantly improved 
by over 83% over the 12-week intervention period, and statistical significance was 
also attained when analysing the strength gains of the entire patient group, as shown 
in Table 3. Muscle strength improvements in healthy muscles as a result of exercise 
training are to be expected, and the results of the present study provides ample 
evidence of the benefits that can be gained from a patient specific, functional exercise 
program. The highly favourable response to training is likely to be due to the low-
level of pre-training fitness, as the majority of this patient group have been sedentary 
for a number of years, due to the reduced mobility and the fatigue they experience 
when they are active (Spector, et al., 1997). 
Figure 2 presents the overall mean change in muscle strength of both the 
compliant and non-compliant patient groups at the completion of the exercise 
program. The compliant patients experienced over a 38% increase in muscle strength 
for all muscles trained, which was significantly different to the average change in 
muscle strength experienced by the non-compliant patients. This figure emphasizes 
the importance of undertaking the exercises as prescribed and instructed, and supports 
the hypothesis that an exercise training program can result in muscle strength 
improvements in this patient group. The findings in this study support work by 
Spector et al. (1997) who found significant strength changes following a short-term 
exercise program in ffiM patients. 
Almost all healthy muscles (trained or untrained) showed an increase in 
strength post-training (Table 1 ). One exception to this is elbow extension, which on 
average experienced a loss of strength over the study. The elbow extensors were 
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'trained' in as much as they were involved in the sit-to-stands all patients were 
required to undertake. Each patient was asked to use their upper limbs to lower 
themselves back into a seated position after each repetition for each sit-to-stand set 
performed by the patient. The limitation of this is that the effort and concentration 
required by the patients to perform the sit-to-stands may have potentially resulted in 
the patients not following the instructions of using their arms to lower themselves 
back into a sitting position. 
However, this study was initially designed to exercise the patients usmg, 
where possible, functional and multi-joint exercises to make the program time and 
energy efficient but also with transfer into activities of daily living. The muscular 
fatigue experienced by this patient group, limits the amount of time and the intensity 
of effort the patients can apply to their program, so an exercise plan that has the 
patient training numerous muscles through a small number of exercises will not only 
be well tolerated by the patients, but encourage compliance as opposed to longer 
exercise sessiOns. 
In analysing the results, and using information provided by the patients in both 
subjective interviews and diary recordings, it is possible to present some interesting 
figures through a case study. Figures 3a and 3b are a comparison between two 
patients, with Figure 3a a pre-post comparison of the mean muscle strength data for a 
single, compliant patient, whilst 3b presents the same values, but for a single, non-
compliant patient. The compliant patient recorded a statistically significant difference 
between pre mean muscle strength score for all trained muscles. This patient was 
highly compliant, undertaking the exercise program as instructed, and was assisted 
through positive reinforcement and constant and strict supervision by their partner. 
The patient's diaries were very detailed and both the patient and their partner strongly 
expressed the view that very few, if any, exercise sessions were not completed. The 
patient's mean strength improved from 5.9±0.6 Kg-f pre-training, to 7.3±0.8 Kg-f 
post-training. 
This is in contrast to the non-compliant patient, who not only missed exercise 
sessions, but also failed to perform the exercises in each session as instructed. This 
patient failed to record any exercise information, which makes it difficult to quantify 
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how much exercise the patient performed, despite the encouragement and close 
monitoring provided by the investigator. However, in interviews with the patient, it 
was clear that they had performed very little of the exercise programme, and thus 
were assessed as being non-compliant in this study. The patient averaged 13.2±1.3 
Kg-fin muscle strength pre-training, but experienced a non-significant loss in strength 
over the 12-week intervention period and recorded a mean value of 12.7±1.2 Kg-f 
post-training. 
In comparing the muscle strength results of these two patients, they provide 
further evidence of not only the capacity of the exercise program to enable the 
patients to attain muscle strength improvements due to a patient-specific, functional 
exercise plan, but also the importance of adhering to the exercise program. Figure 3b 
shows non-compliance can potentially result in a loss of muscle strength which this 
individual patient experienced, which supports the findings presented earlier in Figure 
1 detailing the loss of muscle strength in grip strength in the absence oftraining. 
The change in functional capacities of the compliant patients in this study, 
whilst not statistically significant, should not be understated. As can be observed 
from Table 2, in all three functional tests, the compliant patients improved following 
the training intervention. The time taken to climb one flight of stairs was reduced 
from an average of 19.4±10.7 seconds pre-training to 15.2±6.1 seconds post-training. 
The 30 metre walk time also decreased following the training intervention, from 
43.4±20.4 seconds to 29.8±8.8 seconds. The reduced walk time was accompanied by 
a reduction in the number of paces used by the patient to perform the walk, with the 
compliant patients averaging 67.0±20.0 steps pre-training and 52.8±7.2 steps post-
training. This reduction in number of paces used to perform the walk is indicative of 
the patients developing a larger amplitude gait. 
In the absence of statistical significance, a clinical perspective can be applied 
to the functional improvements seen in this study, whereby for various reasons, such 
as small subject numbers and the insensitivity of the tests in detecting change (Rider, 
1996), the patients did not achieve statistical significance, the improvements seen may 
be viewed as an example of clinically significant results. Additionally, the progressive 
nature of. the disease, which has been shown to cause the patients to lose muscle 
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strength, may have had a limiting effect on the improvements in functional capacity 
over the 12-week intervention period. However, mild improvements, as seen in this 
study group, have important functional implications in the patients' activities of daily 
living. The ability to walk faster over a set distance means less energy is expended 
and the patient can therefore walk further in the absence of fatigue. This enables the 
patient to be more independent, such that they can go to the shops with their partner; 
they can spend an afternoon in a park without becoming over-fatigued from any 
walking they may have to undertake. 
The ability to walk further and faster may also result in the patient delaying 
the need to use a wheel chair or motorised buggy to locomotor. The immobility that 
accompanies these movement aids has serious implications for future health issues, in 
particular cardiovascular disease and other secondary co-morbidities, as a 
consequence of the sedentary lifestyle the patient is forced to live (American College 
of Sports Medicine, 2000, p.5). Being able to walk more and climb stairs with greater 
ease can simply mean the patient is able to move around their house without the 
assistance of their partner or carer, and activities of daily living can be performed with 
greater ease and confidence by the patient. This would potentially have positive 
psychological benefits for the patients, who are able to feel more independent and 
confident in their ability to perform tasks on their own and contribute to the 
community, and less dependent on their partner, carer or others to assist them. 
Using the same two patients that were identified in Figure's 3a and b, Figures 
4 and 5 provide a contrasting observation of the difference in functional capacity 
changes over the 12-week intervention period by a compliant and non-compliant 
patient. Figure 4 further highlights the importance of adhering to the exercise 
program and the benefits of the patient-specific program itself, as this figure shows 
the functional improvements that can be made by an individual, compliant patient 
over a 12-week period. The patient reduced their stair climb time by 25 seconds, a 
64% improvement in time taken to perform the task, whilst their 30 metre walk time 
was reduced from 125 seconds pre-training to 64 seconds post-training, an 
improvement by over 95%. This descriptive data clearly shows the influence the 
exercise program had on this patient and their capacity to perform simple functional 
task such as a stair. climb. and 30 metre walk. 
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Figure 5 presents data from the same functional tests, but shows the reduction 
in functional capacity resulting from non-compliance to the exercise program. In the 
patient's post-training functional assessment, their time taken to walk 30 meters and 
perform the stair climb increased from their pre-training levels. In the case of the stair 
climb, the patient's time increased by 13%, from 19 seconds pre-intervention to 22 
seconds post-intervention. Their 30 metre walk time went from 31 seconds pre-
training to 50 seconds at the completion of the exercise intervention, an increase in 
time by over 61%. This data adds further weight to the evidence this study provides 
in support of the importance of an exercise program for this patient group in the 
prevention or delaying of a loss of muscle strength and functional capacities. 
The careful and selective prescription of exercise load was primarily based 
upon exercise rehabilitation guidelines for other pathological groups. According to the 
American College of Sports Medicine (2000, p.145) guidelines, for optimal strength 
and functional gains to be attained, the patient should adhere to an exercise program 
that emphasises higher frequencies and longer duration exercise sessions at lower 
intensities. This was adhered to by the investigator when prescribing each patient's 
exercise program. In establishing the patients' exercise programs, the investigator 
deliberately avoided emphasising eccentric muscle contractions for the damaging 
effect on muscles they have been shown to cause (Jones, Newham, Round & Tolfree, 
1986). Rather, multi-joint exercises, isometric and concentric muscular contractions 
were preferentially prescribed along with movements and functional positions that 
emphasised balance and stability within the training program. 
Class-based versus home-based exercise rehabilitation therapy has been 
investigated in a variety of pathological groups (Ashworth, Chad, Harrison, Reeder & 
Marshal, 2005), and the cost-effectiveness, compliance rates, and overall results from 
both strategies have merit (Carmelli, Sheklow, & Coleman, 2006). Home-based 
programs are easy to implement (Ashworth, et al., 2005), accessible to the patient 
(Lim, Moon & Lee, 2005), and encourage compliance (McCarthy, Mills, Pullen, 
Richardson, Hawkins, Roberts, Silman & Oldham, 2004). The impaired mobility that 
typifies an IBM patient gives a home-based exercise program advantages over a class-
based program. Such advantages include the safety and familiarlarity of exercising in 
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the familiar surroundings of their own home, the assistance and encouragement of 
partners, the flexibility to perform the exercises according to their own schedule, and 
the avoidance ofhaving to arrange suitable transport. 
Despite being an integral component of this study, the home-based setting 
with which the exercise program was designed for and performed in presented the 
investigator with a number of challenges. Program monitoring is comprehensively 
more challenging in this home-based study compared to a laboratory or clinic setting 
whereby constant observation and supervision can be applied. Ensuring the patients 
perform the exercises, use the correct techniques and apply the appropriate training 
load are just a number of the issues that confront the investigator when establishing a 
home-based therapeutic intervention. Controlling external factors, such as other 
activities and chores the patient undertakes which may impact on the patients fatigue 
and muscle weakness levels whilst partaking in the exercise program, is also an issue 
that requires further examination. Verbal instructions with regards to the importance 
of recovering between exercise sessions and limiting the amount of strenuous 
activities performed during the study period was impressed upon the patients. 
However, it is both unethical and unfeasible to ask the patient to abstain from 
any activities that may make them tired or weak on the premise that this will 
negatively impact on their capacity to consistently perform their exercise program. 
Future studies need to consider this point, and it is recommended that a specific rating 
system of energy exertion during the undertaking of regular, daily activities could be 
useful in attempting to quantify the fatigue levels being experienced by the patients 
when performing these activities of daily living. This would enable the investigator to 
closely monitor the patients' energy and fatigue levels, and then prescribe exercise 
accordingly. In order to establish if exercise should be prescribed as part of the 
routine clinical management of IBM patients', it was felt that it should be determined 
if exercise training in the patients' home is practically achievable and therefore we 
considered that the nature ofhome-based exercise was integral to this study. 
In evaluating the completed diaries of the patients, there was much variability 
in the amount of the exercise program performed by each patient. Two of the patient 
group did_not attempt to. fill out a diary, so it is difficult to make a formal conclusion 
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on the adherence to the program by the patient's, other than what was verbally 
communicated to the investigator by each patient in subjective interviews at the 
completion of the exercise program. For reasons such as an illness, having friends 
staying with them, or having to go away from home, five of the patient's felt that they 
missed a small percentage of days within the intervention period, but never for more 
than 5-6 days at a time, and this is supported by diary entries by this subset of 
patients. The non-compliance of two of the patient's in the study group was the 
reason why the investigator took the approach of analysing the results in two separate 
data sets. 
Despite ngorous efforts to encourage and monitor patient compliance, 
ensuring the patients adhered to the exercise program and performed the training as 
prescribed was challenging. Physicians should therefore consider this when 
prescribing exercise to this clinical population. The program was developed to ideally 
exist in the absence of daily interactions with the investigator and the associated 
constant supervision, as it was the intention of the investigator to develop the program 
in such a way so as to make the exercise program a behavioural change and an 
addition to the patients' everyday lifestyle, not something the patients were forced to 
do and travel to and from a gym or clinic to undertake. 
Despite encouraging self assessments from each patient with regards to their 
adherence to the exercise program throughout the intervention period, it is difficult to 
make any formal conclusion of overall compliance to the program with the variability 
that existed between each patient in their diary entries and without the factual 
information of how often the patient actually performed the exercises that the diary 
was intended to provide. In consideration of the non-compliance by two patients in 
this study, some viable recommendations could go some way to ensuring future 
similar studies are not hindered by the issue of non-compliance, or at least the lack of 
indisputable facts needed to make sufficiently justified statements of the training load 
each patient performed. A more interactive method of program monitoring could 
provide' the necessary stimulus required to ensure the patients are not only 
undertaking their exercises, but also to further encourage them to maintain their 
exercise diaries, regardless of what they did or did not do. More regular contact via 
phone calls and possibly, more home-visits by the investigator are two realistic means 
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of increasing the investigator/patient contact. 
A more direct involvement by each patient's personal support network could 
also lead to improvements in patient self-assessment and exercise recording. This 
could involve simply having the patients' wife/husband/child listening in on all 
meetings between the investigator and patient and being involved in the 
implementation of the exercise program into the patients home. Obviously, the 
patient is given the opportunity to involve who they wish and invite them along to any 
and all meetings between themselves and the investigator, but additional 
encouragement to do this by the investigator could ensure every patient has the 
necessary support to undertake the exercise program. Taking this a step further, it 
would be quite possible to involve the patient's partner in the actual exercise program 
and make the exercise therapy a joint interest the patient and their partner could share 
with potential positive benefits for both. Having someone in the patients home to act 
as 'interactive supervisors' in the absence of the investigator to ensure the exercises 
are correctly undertaken and recorded, provide encouragement and positive 
reinforcement and to ensure the safety of the patient is an important facet of home-
based exercise programs if they are to be successful. 
Another option that may potentially have a positive effect on the compliance 
of the patients to the program and also stimulate them more to record their progress is 
the establishment of a once-weekly group exercise session delivered in a gym-type 
setting. Balance and physical performance has been shown to be improved as a result 
of class-based, supervised exercise programs in older adults (Carmelli, Sheklow & 
Coleman, 2006; Judge, 2003). This would provide the patients with motivation to do 
their exercises in the knowledge that their progress will be more closely followed by 
the investigator when they attend these sessions each week. It would also provide the 
investigator with the opportunity to deliver more specialised exercise programming 
and work more hands on with the patients in a rehabilitative setting. The social aspect 
of having a group of patients with the same disease interacting and supporting each 
other would likely have a positive influence on the patients and provide further 
motivation to attend each week knowing a friend will be there and is facing the same 
problems and daily issues as them. This is particularly prevalent in this pathological 
group exhibiting a muscle disease that is seemingly quite uncommon. Whilst 
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conflicting evidence surrounds the impact of home-based and class-based exercise 
programmes, further research is required to assess why patients are/are not adhering 
to exercise programs and diligently recording their performance, regardless of the 
setting. This would then provide investigators with the fundamentals necessary to 
establish research projects designed to enable investigators to make conclusive 
statements on the type of exercise setting that will best induce optimal training effects. 
The role CK plays during exercise has been comprehensively examined, 
resulting in CK levels being the primary biochemical marker of muscle damage 
following a bout of exercise (Clarkson & Tremblay, 1988; Houmard, Costill, 
Mitchell, Park, Fink & Bums, 1990; Shahbazpour, Carroll, Riek & Carson, 2004; 
Totsuka, Nakaji, Suzuki, Sugawara & Sato, 2002). It is felt that CK is a reliable 
measure of muscle damage following , exercise in myopathic patients (Phillips & 
Mastaglia, 2000). However, studies on inflammatory myopathy patients have shown 
that despite an immediate rise in CK levels following strength training, the rise does 
not seem to be sustained for any more than a few hours, and certainly with no long-
lasting changes in the patients CK levels following exercise have been observed 
(Amadottir et al., 2002; Escalante, Miller & Beardmore, 1993; Hicks, Miller, Plotz, 
Chen & Gerber, 1993; Spector, et al., 1997). This study did not result in significant 
serum CK changes, thus supporting previous findings that exercise can be safely 
tolerated by this patient group. 
The small number of subjects in this study has implications for the statistical 
power of the results and the subsequent conclusions drawn from the data. However, 
with the muscle disease being quite rare, the actual numbers which make up this study 
are comparative to other exercise therapy studies involving neuromuscular disorders. 
The progressive disabling nature of the disease and the symptomatic muscle weakness 
and fatigue caused a number of patients to withdraw from the study either prior to it 
beginning or during the intervention period. The decision to withdraw was often 
made apologetically and whilst most wanted to continue or start the exercise program, 
they simply felt that the exercises were not going to help them and it would therefore 
be a waste of their time and effort. 
The assessment, of muscle strength by a hand-held myometer, which IS 
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employed regularly in clinical settings, provided accurate, valid and reliable results 
(Agre, Magness, Hull, Wright, Baxter, Patterson & Stradel, 1987; McMahon, Burdett 
& Whitney, 1992), as did the testing of the patient's functional ability. The functional 
tests performed by the patients are commonly clinically applied in the testing of a 
variety of muscle disorders. The aerobic testing of the patients was quite a novel 
procedure for this pathological group, but it was carefully planned and designed to 
account for individual differences between the patients and any co-morbidities that 
were present. The testing procedure was thoroughly researched and critically 
assessed prior to being used, and was based on a number of similar protocols 
established in the testing of other symptom-limited pathologic groups. 
The testing procedures used in this study were reliable and valid measures of 
both muscle strength and functional capacity and inter-rater reliability was confilmed 
for all measures tested. However, the importance of assessing the impact of any 
exercise intervention on a clinical population's quality of life (QOL) should be 
prioritised and should be a key outcome measure in studies such as this one. 
Improvements in muscle strength and endurance are vital, but it is how these changes 
advantage the everyday lives of the patients and improve their functionality that is the 
key issue. Currently, further research is required to develop valid, reliable and 
sensitive QOL scales for this particular patient group. 
The use of the SF-36 as the quality of life instrument to assess general health 
and functional changes as a result of the training intervention is based on it's 
prevalence in the literature pertaining to similar studies of neuromuscular patient 
groups. Despite it not being a muscle disease specific measure, it has been shown to 
be a valid and reliable measure of a patient's overall health status (Alexanderson, 
Stenstrom & Lundberg, 1999). The SF-36 was trialled in this study, but in reviewing 
the patients' pre- and post-intervention questionnaires, the investigator found the 
questionnaire lacked specificity when applied to this particular clinical population. 
Despite its application in a number of liM studies (Isenberg, et al., 2003; Sultan, 
Ioannou, Moss & Isenberg, 2002), the validity of the SF-36 as a QOL measure for 
IBM patients needs further clarification. 
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6. Conclusion 
In IBM patient's, significant strength gains can be attained in non-diseased 
muscles, strength can be maintained in the diseased muscles, and functional 
improvements can be made in the absence of muscle damage as a result of a home-
based, patient-specific, functional exercise program. In normal populations, a muscle 
that has experienced atrophy can regain size and strength through resistance training, 
however, studies have shown that strength training does not seem to cause muscle 
hypertrophy in IBM patient's, or at least it does not do so to a sufficient number of 
muscle fibres required to make a significant contribution to result in a change in 
muscle size (Phillips & Mastaglia, 2000; Spector, et al., 1997). Other possibilities 
which may explain the increase in muscle strength observed in this patient group 
following the exercise intervention include a ·change in fibre type (Alexanderson & 
Lundberg, 2005; Arnadottir, et al., 2002) and recruitment patterns. An increase in 
muscle fibre cross sectional area has been seen in muscle biopsies following an 
exercise intervention in IBM patients; however, a significant result was not 
established and questions remain as to whether or not muscle undergoes hypertrophy 
in response to a strength training program (Arnardottir, et al., 2002). 
Motor learning and an improvement in the co-ordination of muscles activated 
during the performance of a task may also contribute to strength gains and functional 
improvements. We propose that the present approach has been beneficial to the 
patient's by slowing muscle atrophy and improving co-ordination and activation of 
muscle groups to perform a given task. Although improvement in the functional tasks 
did not reach significance, the use of functional weight-bearing activities in the 
exercise program may assist the patient in average daily living activities (Littbrand, 
Rosendahl, LindelOf, Lundin-Olsson, Gustafson & Nyberg, 2006; Wilson, Murphy & 
Walshe, 1996). It should be considered that the sample size used in this study is 
likely to have affected the statistical power of the data analysed. The results are 
particularly promising when taking into consideration that the training did not include 
an aerobic component that could potentially specifically enhance the patient's ability 
to move with greater control, therefore, a reduction in energy expenditure resulting 
:from excessively co-contracting muscles. 
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Exercise guidelines are substantially lacking for this patient group; however, 
exercise has been shown to have a positive effect on an IBM patient's muscle strength 
in previous studies (Amardottir, Alexanderson, Lundberg & Borg, 2002; Spector, et 
al., 1997). This study provides evidence to support the prescription of a carefully 
controlled, patient-specific exercise program. In the absence of disease progression 
markers, this study shows that muscle strength and function can be improved by mild 
daily exercises performed in the patient's home. Key factors such as adherence, 
exercise prescription, the initial training load and the subsequent progression of the 
training program must be considered and thoughtfully planned in any future 
investigations. Exact training protocols and the relevance such strength and 
functional improvements have on the patients quality of life, requires further 
investigation with large sample sizes in controlled, long-term training interventions 
using validated, disease-specific quality' of life scales. This would perhaps require a 
coordinated multi-centre, randomized controlled, clinical trial. However, this study 
has shown that exercise, in particular, strength training, may be an important 
component of the routine management and long-term treatment of patients with 
Inclusion Body Myositis. 
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Appendix A 
Published abstract in the Scholarly 
Journal 'Neuromuscular Disorders'. 
This abstract was presented as a poster 
presentation at the XI. International 
Congress on Neuromuscular Diseases, 
02-07 July, Istanbul- Turkey. This 
abstract was pilot study work the 
investigator undertook prior to the 
commencement of their Honours 
investigation 
Abstracts I Neuromuscular Disorders 16 (2006) S48-S196 SS7 
This mechanism might be the cause of increased myostatin precursor 
demonstrated in s-IBM muscle fibers. Increased myostatin precursor/-
myostatin might contribute to muscle-fiber atrophy and other changes in 
s-IBM. 
Support: grants (to VA)from the NIH, TMA, MDA and the Helen Lewis 
Research Fund. 
M-P-6.04 
Granulysin expression in polymyositis and inclusion body myositis 
Koji Ikezoe*, Sachiko Oshima, Manabu Osoegawa, Masato Tanaka, 
Kazuyuki Ogawa, Kinya Nagata, Jun-ichi Kira 
Japan 
Background: Granulysin, a recently defined cytolytic molecule, is 
expressed in cytotoxic T and natural killer cells; similar to perforin, 
which is reported to play a major role in the pathogenesis of 
polymyositis (PM) and inclusion body myositis (IBM). Objective: To 
clarify the role of granulysin in PM and IBM. Methods: We examined 
the expression of granulysin and perforin by double-staining with CDS, 
CD4, and CD56 in endomysia! infiltrating cells and autoinvasive cells in 
17 muscle biopsies of PM (6 steroid resistant, and 11 steroid responsive), 
and 7 IBM. Results: Similar to perforin, granulysin was expressed in 
CDS+, CD4+, or CD56+_cells in PM and IBM. However, only the 
ratio of cells double positive for granulysin and CDS to all CDS+ cells 
at endomysia! sites was significantly higher in steroid resistant PM than 
in steroid responsive PM and IBM. Conclusion: Granulysin expression in' 
CDS+ cells appears correlated with steroid resistance in PM. 
M-P-6.05 
A pilot study on the effects of a patient-specific, home based, functional 
exercise program on patients with Inclusion Body Myositis (IBM) 
Liam Johnson*, Dylan Edwards, Gary Thickbroom•, Frank Mastaglia• 
Centre for Neuromuscular Disorders, The University of Western Australia; 
School of Exercise, Biomedical and Health Sciences, Edith Cowan 
University; aCentre for Neuromuscular Disorders, The University of 
Western Australia 
Previous research has shown exercise to be beneficial in the treatment 
of myositis-affected patients. The potential of functional exercises to 
improve muscle strength and function in the absence of disease 
progression markers is not well understood. We believe that an exercise 
program tailored to the patient is important for routine management and 
long-term treatment. The present study investigated the effects of a 
home-based, patient-centered functional exercise program, on muscle 
strength and patient mobility. Patients were tested pre and post, a 16 
week, patient-specific, home exercise program involving mild, daily 
functional exercise. Outcome measures included a hand-held dynam-
ometer for muscle strength, whilst a 30 m walk and stair climb was 
performed to ascertain changes in overall functional ability. Inter-tester 
-reliability was confirmed for the measures used. Creatine Kinase (CK) 
was monitored over the intervention period. Strength improved for all 
muscles tested, with results as follows; shoulder abduction 39.4± 
IOSEM%, shoulder external rotation 7±1S, elbow extension 39.2±S, 
elbow flexion 57.7 ± 14, wrist extension 50.7 ±21, hip flexion 169.S±56, 
hip abduction 56.1 ±20, knee extension 36.1 ± 10 and knee flexion 
62.0±24. There was a post-intervention improvement in average time 
taken to climb one flight of stairs (13.S±3 s reduced to 11.5±3 s) and 
walking unaided for 30 meters (41 ±5 s reduced to 34±6 s). The number 
of paces to perform the 30m walk was also reduced (5S.S±3 to 54.S± 
4 ). Serum creatine kinase levels remained constant throughout the 
intervention period. Results from this preliminary study show that muscle 
strength and function can be improved by mild daily exercises performed 
in the patient's home. In the absence of disease progression markers, our 
individually prescribed home exercise program over 16 weeks has shown 
that simple functional exercise activities can be beneficial in the clinical 
management of myositis patients. 
CONGENITAL MYOPATHlliS; POSTER PRESENTATIONS 
M-P-15.01 
A comparative morphological study of heart and skeletal muscle in 
mutation-proven desminopathie 
Hans H. Goebel*, Rolf Schroeder", Walter Schulz-Schaefferb, 
Lev Goldfarbc 
Department of Neuropathology, Johannes Gutenberg University Medical 
Center, Mainz, Germany; a center for Biochemistry, University of Cologne, 
Germany; bDepartment of Neurology, Georg-August University, Goettin-
gen, Gennany; " National Institute of Neurological Disorders and Stroke, 
National Institutes of Health, Bethesda, Maryland, USA 
Background: Desminopathies are molecularly marked by mutations in 
the desmin gene, clinically by musle weakness, often of late onset and more 
distal than proximal, and frequently cardiac disease, morphologically of 
degeneration of sarcomeres and aggregation of desmin and many other 
proteins appearing as inclusions or wide spread granulofilamentous 
material within muscle fibers. Purpose: To assess the morphology of 
cardiac pathology and compare it with myopathology in skletal muscle 
fibers in mutational desminopathy. Material: Cardiac tissue obtained by 
biopsy or explantation for heart transplantation of three genetically affected 
patients. Methods: Histology, immunohistochemistry, electronmicroscopy. 
Results: Myocytes in both skeletal muscle and heart gave identical 
disruption of sarcomeres and accumulation of granulofilamentous material 
often amassed at the intercalated discs of cardiomyocytes and beneath the 
sarcolemma in skeletal muscle fibers. Conclusion: As desmin is the 
intermediate filament of both skeletal muscle fibers and cardiomyocytes 
encoded by the same gene with, hence, mutations in the DES gene affecting 
both organs the similar pathomorphology underscores such genotype-
morphotype correlation and forms the basis for clinical involvement of 
skeletal muscle and heart. 
M-P-15.02 
Severe nemaline myopathy caused by mutations of the stop codon of the 
skeletal muscle alpha actin gene (ACTA1) 
William Wallefeld*, Sabine Krause•, Kristen Nowak· Rita Horvath•, Zoltan 
Molnarb, Miklos Szabob, Ichizo Nishinoc, Hanns Lochmiiller•, Nigel Laing 
Molecular Neurogenetics Laboratory, Centre for Medical Research, 
University of Western Australia, Western Australian Institute for Medical 
Research, B Block, Queen Elizabeth II Medical Centre, Nedlands, Western 
Australia; a Molecular Myology Lab, Friedrich-Baur-Institute, Department 
of Neurology, Ludwig-Maximilians-University of Munich, Marchioninistr. 
17, 81377 Milnchen, Germany; bFirst Department of Pediatrics, 
Semmelweis University, Bakay u. 53, 1083 Budapest, Hungary; <Depart-
ment of Neuromuscular Research, National Institute of Neuroscience, 
National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawahiga-
shi-cho, Kodaira, Tokyo 187-8502, Japan 
P.urpose: Most nemaline myopathy patients have mutations in the 
nebulin (NEB), or alpha-skeletal actin (ACTA!) genes. We have 
performed screening of the ACTA! gene in multiple patients with 
congenital myopathies from Europe and Japan. Here we report for the 
first time mutations of the ACTA! stop codon in two patients, one from 
Hungary and one from Japan, with severe nemaline myopathy with 
dystrophic changes on muscle biopsy. Methods: All six coding exons of 
the alpha-skeletal actin gene were sequenced from genomic DNA using 
our previously published methods. Western blotting was performed using 
an antibody to sarcomeric actins. One of the stop codon mutations was 
cloned into pEGFP-Nl (Clontech) and expressed in C2C12 cells 
according to our previously published protocols. Results: A heterozygous 
TAG>CAG (glutamine) mutation of the ACTA! stop codon was 
identified in the patient from Hungary and a heterozygous TAG>TAT 
(tyrosine) mutation in the Japanese patient. Both mutations will cause 
inclusion of an additional 47 amino acids, translated from the 31UTR of 
the gene, into the mature actin protein. Western blotting performed on 
AppendixB 
Diagnostic criteria for the diagnosis of 
sporadic-IBM 
Table 3.2. Diagnostic criteria for s-IBM 
I. Characteristic features 
A. Clinical 
1. Duration of illness: more than 6 months 
2. Age of onset: more than 30 years old 
3. Muscle weakness must affect the proxinuil and distal muscles of 
arms and legs, and . 
the patient must exhibit at least one of the following features: 
(a:) Finger-flexor weakness 
(b) Wrist-flexor weakness greater than wrist-extensor weakness 
(c) Quadriceps-muscle weakness (grade 4 MRC) 
B. Laboratory 
1. Serum creatine kinase less than 12 times normal · 
2. Muscle biopsy 
(a) Inflammatory myopathy characterized by mononuclear-cell in 
vasion of non-necrotic muscle fibers · 
(b) Vacuolated muscle fibers \,\ OOEth~ ,, 
(i) Intracellular amyloid deposits (must use fl.uoresce·nce 
method of identification before excluding the presence of 
amyloid) or 
(ii) 15-18-nm tubulofi.laments shown by electron microscopy 
3. Electromyography findings must be consistent with the features of 
an inflammatory myopathy (i.e., irritable myopathy); long-duration 
potentials are commonly observed and do not 
exclude a diagnosis of s-IBM 
c; Family history 
Rarely. s-IBM can be observed in families. This condition is 
different from h-IBM without inflanunation. Familial cases of s-IBM 
require documentation of the inflammatory component by 
muscle biopsy, in addition to vacuolated muscle fibers, intracellular 
(within muscle fibers) amyloid, and 15-18-nm tubulofilaments. 
D. Associated disorders 
IBM can occur with a variety of other disorders, especially immune-
mediated conditions. The presence of an associated condition does not 
preclude a diagnosis of s-IBM if the following diagnostic criteria are 
met. 
II. Diagnostic criteria for s-mM 
A. Definite s-IBM 
Patients must exhibit all muscle biopsy features, including invasion of 
non-necrotic fibers by 
mononuclear cells, vacuolated muscle fibers, and intracellular (within 
muscle fibers) amyloid deposits or 15-18-nm tubulofllaments. None of 
the other clinical or laboratory features are mandatory if the muscle 
biopsy features are diagnostic. 
B. Possible s-IBM 
If the muscle shows only inflammation (invasion of non-necrotic muscle 
fibers by mononuclear cells) without other muscle biopsy features of 
IBM, then a diagnosis of "possible s-IBM" can be made if the patient 
. exhibits the characteristic clinical (I.A.1,2,3) and laboratory (I.B.1,3) 
features. Neither I.C nor I.D should exclude a diagnosis of s-IBM. · 
Griggs, R.C., Askanas, V., DiMauro, S., Engel, A., Karpati, G., Mendell, J.R., & 
Rowland, L.P. (1995). Inclusion body myositis and myopathies. Annals of 
Neurology, 38(5), pp.705-713; 
Appendix C 
Patient consent form signed by each 
patient that took part in the study 
CONSENT FORM 
The Effectiveness of a Home-Based, Patient-Specific, Functional 
Exercise Program on Patients with Inclusion Body Myositis (IBM) 
Investigators: Professor Frank Mastaglia, Dr G Thickbroom, Dr Merrilee 
Needham, Dr Dylan Edwards and Liam Johnson 
Subject Name: __________________ _ 
Date of Birth: ______ _ 
1. I have been given clear information (verbal and written) about this study 
and have been given time to consider whether I want to take part. 
2. I have been told about the possible advantages and risks of taking part in 
the study and I understand what I am being asked to do. 
3. I have been able to have a member of my family or a friend with me while I 
was told about the study. I have been able to ask questions and all 
questions have been answered satisfactorily. 
4. I know that I do not have to take part in the study and that I can withdraw 
at any time during the study without affecting my future medical care. My 
participation in the study does not affect any right to compensation, which I 
may have under statute or common law. 
5. I agree to take part in this research study and for the data obtained to be 
published provided my name or other identifying information is not used. 
If you are unclear about anything you have read in the Patient 
Information Sheet or this Consent Form, please speak to your doctor 
before signing this Consent Form. 
Name of Patient 
Date 
Name of Investigator 
Date 
Signature of Patient 
Signature of Investigator 
The Sir Charles Gairdner Hospital Human Research Ethics Committee has 
given ethics approval for the conduct of this project. If you have any ethical 
concerns regarding the study you can contact the secretary of the Sir Charles 
Gairdner Hospital Human Research Ethics Committee on telephone No. (08) 
. 9346.3528. 
AppendixD 
Muscle Assessment form used by 
investigator to record the patients 
muscle strength results 
MUSCLE ASSESSMENT 
NAME: ____________ CUNlC NO: __ DATE: __ _ 
fSOMETR fC TESTING 
Shoulder abductors 
Shoulder ex l. rotators 
Elbow extensors 
Elbow flexors 
Wrist extensors 
Hip flexors 
Hip abductors 
Neck flexors 
Grip strength 
Knee ex tensors 
Knee flexors 
Ankle dorsif!exors 
TIMED TESTS 
I Stairs 
2 Walking 30m/10m 
3 Timed Stands 
FUNCTIONAL TESTS 
I Sit U[1 rrom lying 
2 Rise from squat 
Weight 
Med iotior1:--
MRC R i__g_ h t Left 
-----·~• n >~- I --------
No. Paces 
Yes/No 
Ycs/~t) 
MRC 
-~- .. --
I 
I 
AppendixE 
Muscle strength assessment positions 
for hand-held myometry 
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Appendix F 
Penny and Giles Transducer Muscle 
Myometer used to assess the patients 
muscle strength in selective muscles 
bilaterally 
Penny and Giles Transducer hand-held myometer- used to measure the patients muscle 
strength in selected muscle bilaterally. 
Appendix G 
Short Form-36 Health Survey used to 
assess the patients change in general 
health and well-being as a result of the 
exercise intervention 
SF36 Health Survey 
/f~,§m.~y~·~J~~.~~R.:;){:\;li~:set of questions ~sks for your views about your 'health. TJj}~ -!~t()rrf1.%ti8rt;.''·'> ~­
.\Ntll help.:!<eep.·track of how you feel and howwell you are able to do your usiJai acttvttres ... Answer' :;:~y~~~\}¥·g~)~\1;~~f;~~A~·~fbi'ng tne·answef'$sih<:Jicated. If you·are unsure about··t160to ~·~~w~:i.~:l'·• · T 
'q1J~$'ti'Oo<t:>T€f~j3gd~IY:~Jh'e best answer. you can, , , . · . , , , 
In general, would you say your health is: (Please tick one box.) 1. ~ Excellent _, 
2. 
3. 
3(a) 
Very Good J 
Good J 
Fair -] 
Poor J 
Compared to one year ago, how would you rate your health in general now? (Please tick one box.) 
Much better than one year ago . :J 
Somewhat better now than one year ago :J 
About the same as one year ago :J . 
Somewhat worse now than one year ago :J 
Much worse now than one year ago :J 
The following questions are about activities you might do during a typical day. Does your health 
now limit you in these activities? If so, how much? (Please circle one number on each line.) 
Activities 
Vigorous activities, such as running, lifting. heavy objects, 
Yes, 
Limited 
A Lot 
Yes, 
Limited A 
Little 
2 
Not 
Limited 
At All 
3 
.. P.~0.i.Y.i.P.~~.i.l).9. !.t:J .. ?.tr_e.lll1.0.L1 :3. spqrt? ........................................................................................................................ . 
3(b) Moderate activities, such as moving a table, pushing a 2 3 
... Y.?. ~\J !:l.r:-0.. ~)~.?D~X , .. 1?.9~!! ~9.,. (l.r. P..I.E.JYi.Cl9 .. 9 9!!............................. ... . . . . . . .. . .. . . . . ............................................................. . 
3(c) ... ~.\H!!!9 .. 9f .. ~~f.IY.!~9..9f.~~~.~i.~::? ...................................................................... ......... ! .......... ........... ? ................... .3. ........ . 
3( d) ... ~.1!!!1.~\r1.9 .. ~~.Y.~r.~!. !.l.i.9.~~.~ .. 9 f..~.~?. ir.~~ ..................................................................... ~ ..................... ? .................. ..3. ........ . 
. 3( e) ... ~.1)!!1.~lr19 .. ~.~~}1.i.9bt9L~.~?.!r.~ ...................................................................... ......... ! .. ~ ....... ........... ? ................... ) ........ . 
3( f) ... I?.!?Dg).t:J.9,.~.t:l.~~.l.i!:'.9 , . .<?X. :?.~C?.q P..i.t:l.9 ........................................................................ ! .............. ~ ..... ? ................... } .. ...... . 
3(g) ... IJY.?.Er19 .. ~.<?.r.e..t.h.~.n .. ~ .. ~.H.e............. .... ..................... . ..................................................... ? ........... ........ } 
3(h l ... IJY.?.\~lr19 .. ?.~Y.~r.~! .. I?.!C?.c::.~~ ........................................................................................................... ?. ................... ~ ........ . 
3(i) ... IJY.?.\~!r19 .. 9!~.~}~!C?.S:~................................................... . .................................................... ~ ................... .3 ..... .. 
3(j) Bathing or dressing yourself 2 3 
4. 
4(a) 
4(b) 
4(c) 
4(d) 
5. 
5(a) 
5(b) 
5(c) 
During the past 4 weeks, have you had any cif the following problems with your work or other 
regular daily activities as a result of your physical health? 
(Please circle one number on each line.) Yes No 
.. q l1.~. 9.C?.'t.'.ll. ~n. t.~. ~. !3.~ C?.l1 .n.t .. 0. f .. t i "!...e.. Y.<?.l!.::? P..~ r1 t_ .9 t1 .. 't.'~ r.k. 9. r .. o.t ~ _e.r. C3.c.~i_yi ti ~ ~............... . ........ ~......... . ........ ~ 
.. f.':~~~.r:-0.P.!!:?0.~9 . .1.~.~?..~.~.?.f.l . .Y9!:! .. W..C?.l1J9 . .1.i.~~ .................................................................................. L ............... ? ........ . 
.. W..~r~ .. Hf'!.l.i.~~~,Ut1 .. t.~~ .. ~!~.~ . .<?.(.~(l.~~-~r.~.t.l:~r..~~~.i.v.iJ.i.e.? ........................................................... ..1. ................ J ....... . 
Had difficulty performing the work or other activities (for example, it took 
extra effort) 
2 
During the past 4 weeks, have you had any of the following problems with your work or other 
regular daily activities as a result of any emotional problems (e.g. feeling depressed or anxious)? 
(Please circle one number on each line.) Yes No 
.. q!:I.~.9~.':Y.Il.~n.tb.~.~-~C?.l1.n.! .. o.f..~!~.e..Y.(l.Y..~P..~r1~ .. 9~ .. w..o.~~ . .o.r . .c?.t~.~~--E.J.Y.\iyi.t!~~ ......................... 1 .................. ? ........ . 
.. f.':~~.<?.l:~P.!.i§b.~9 . .1.~.?.?..~b.~!.l .. Y.c?.l1 .. W..f?.l1)9 .. \i.~~- ............ : ...... ·· .............................................................. ) ................... ~ ........ . 
Didn't do work or other activities as carefully as usual 1 2 
6. 
7. 
8. 
9. 
9(a) 
9(b) 
9(c) 
9(d) 
9(e) 
9(f) 
9(g) 
9(h) 
10. 
11 . 
During the past 4 weeks, to what extent has your physical health or emotional problems interfered 
with your normal social activities with family, friends, neighbours, or groups? (Please tick one box.) 
Not at all :1 
Slightly :1 
Moderately :1 
Quite a bit :1 
Extremely :1 
How much physical pain have you had during the past 4 weeks? (Please tick one box.) 
None :1 
Very mild :1 
Mild :J 
Moderate J 
Severu J 
Very Severe J 
During_ the past 4 weeks, how much did pain interfere with your normal work (including both work 
outside the home and housework)? (Please tick one box.) 
Not at all J 
A little bit J 
Moderately :J 
Quite a bit J 
Extremely :J 
These questions are about how you feel and how things have been with you during the past 4 
weeks. Please give the one answer that is closest to the way you have be.en feeling for each item. 
All of Most A Good Some A Little None · 
the of the Bit of of the of the of the (Please circle one number on each line.) 
Time Time the Time Time Time Time 
.. P.i.Q.Y9.\-!J~?.~Lf.Y.!L9! .. 1.i.(~1 ................................................ L ........... 2....... .... 3 ........ ...... A ....... ..... 5 ............. ?. ..... .. 
.. tl.?.\JE? .. Y(J!:' .. Q~.<?.f! .. <?.Y!=:.ry.f1_!?.1Y9.l,l.:".P..~r.s.<?.r17. ............. 1. ........... 2. . 3 ...... A ............. ~ ............. ?. ...... . 
Have you felt so down in the dumps that 1 2 3 4 5 6 
.. f! 9.~ ~ l r-!.9. ~(J.YJ.?.. S:b.~ ~r. Y9.l,l .. ~ P..?. ... .. . .... .. . . .. .. . .. . . .. . .. .. . .. . . .. .. . . . . . . . . . . . . . . . .. .. . . . . . . . . . .. . . . . . .. . .. . . . .. . . . .. . . . . . .. . .. . .. .. .. .. ............. . 
.. tl.?. \J~ .. Y(J!:'J~.I~ .. ~?.! !T.l. .?. r-!.9 .. P. .~.?. ~~-~Y.!? ........................... ! .............. ?. .. . .. . . ........ 3......... . ... .. A....... .. ..... ~....... .. ..... ?. ..... .. 
.. Q[Q.Y9.Y..b.~~~ .. ?..!(JJ..Qf..?.!!.~X9Y.?. ............................ ....... ! ....... ...... .? .............. .3. .............. .4 .............. ~ .............. ?. ...... . 
.. t1.?.\JE? .. Y.()~J~Jt9.9:-:Ynh~.<?.\1~.9 .. ~D9 .. 9.!\-!~.?. ........ : ........... L ......... ..?.. .............. 3. ........ ...... A ....... ....... ~ .............. ?. ..... .. 
.. Qi.~tY9.Y..f.?.~l.:-:Y9X!'! .. ~~~-?. ......................................... ..... ..! ....... ....... ?. .. : ........... .3. ........ ...... A ....... ....... ~ ............ ..tL.o' .. 
.. tl.?. \J~ .. Y.Q~ .. ~f?.?. r! .. ~ .. h~.P.P.Y .P. f? .I:?.Qfl.?....................... . ...... 1 .............. ?.. . . . .. . ........ 3......... . ..... A....... . ...... ~-...... .. ..... ?. ..... .. 
Did ou feel tired? 1 2 3 4 5 6 
During the past 4 weeks, how much of the time has your physical health or emotional problems 
interfered with your social activities (like visiting with friends, relatives etc.) (Please tick one box.) 
All of the time 0 
Most of the time 0 
Some of the time 0 
A little of the time 0 
None of the time 0 
How TRUE or FALSE is each of the following statements for you? 
(Please circle one number on each line.) Definitely 
True 
Mostly 
True 
Don't 
Know 
Mostly 
False 
Definitely 
False 
11(a) I seem to get sick a little easier than 2 3 4 5 
.5?~.l:t ~! .. P. f?.Q.P.lf? ................................................... ·. . .. . . . . . . . . .. . . .. .. . . .. . . . . . . . . .. .. . .. . . . . .. . . . .. . . .. . . .. .. . . . . . .. .. . .. . .. .... . . .. . .. .................. .. 
11 (b l . .!.i?.r:TI.9.9 .. h!?.?.!tDY .. ~:".9X!Y.!?.<?.9Y...I .. tfl9.'!Y: ...................... J .................... 2. ............... :3 ........ ........ A......... .. ........ !?. ........ .. 
.. ! . !?.~.P.~_<;:t..rr!Y .. ~-~!?.1.\h. ~.9.. 9.~.~ .~9!.:"~ ............................ J ..... · ............... ) . . .. . . . . . ...... :3 .............. .. A......... .. ........ !?. ......... . 
1 2 3 4 5 
Thank You!. 
Appendix H 
Exercise Training booklet each patient 
was given, illustrating and describing 
sample exercises 
SAUNDERS' 
EXERCISES 
~~~XPRESS'"' 
EXEROSE SOFIW ARE 
© PhysioTools Lid 
© PhysioTools Lid 
© PhysioTools Lid 
© Ph JSio Tools Lid 
Built on Tools® 3.0 
Personal Exercise Program 
Chest and Anterior Shoulder (Right arm) 
Hold on to a high object with the right hand, keeping the right arm straight. Turn 
the feet to the left and roti;lte the body to the left feeling the stretch across the front 
of the shoulder. 
Hold for sees. 
Repeat __ times. 
Stand or sit. 
Stretch one arm over to the opposite shoulder by pushing it at the elbow with your 
other arm. Hold the stretching approx. 20 sees. - relax. 
Repeat_ times. 
Calf Stretch (Soleus) (Right leg) 
Begin in a half-lunge position with your front leg bent, hands supported on the wall. 
Lower your body towards the wall, pressing your leading foot into dorsiflexion. 
Hold for sees. 
Repeat __ times. 
Half Lunge (Rightleg) 
Begin half kneeling, and tighten your abdominal muscles to stabilise your trunk. 
Press your trailing leg forwards, forcing your right hip into extension. 
Hold for sees. 
Repeat __ times. 
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© PhysioTools Ltd 
© PhysioTools Ltd 
,("\ 
\ \ 
I : P\ ~ 
© PhysioTools Ltd 
© Ph ysio Tools Ltd 
© P;·ysioTools Lid 
Built on Tools® 3.0 
Gluteal Stretch (Right leg) 
Lie on the floor with left leg straight. Flex the right knee and pull it upwards and 
across towards the opposite shoulder. 
Hold for sees. 
Repeat __ times. 
Hamstring Stretch (Active knee extension) (Right leg) 
Lie on the floor, flex your hip to 90°. Grip your hands behind the knee and actively 
straighten the knee using your quadriceps muscles. 
Hold for sees. 
Repeat __ times. 
Lying on your back or sitting. 
Bend and straighten your ankles briskly. If you keep your knees straight during the 
exercise you will stretch your calf muscles. 
Repeat_ times. 
Sitting with your foot on the floor. 
Alternately raise the inner. border of your foot (big toe) and then the outer border 
(little toe). 
Repeat_ times. 
Support your elbow on a table with your wrist straight and your fingers pointing 
towards the ceiling. 
Make a fist (thumb over fingers). Straighten your fingers and bring them apart. 
Repeat_ times. 
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©Physic Tools Ltd 
©Physic Tools Ltd 
© Physic Tools Ltd 
Built on Tools® 3.0 
Support below the finger joint to be exercised.· 
Bend the middle joint of the finger. Assist the movement with your other hand. 
Hold sees. 
Repeat_ times. 
Support the wrist of the hand to be exercised. 
Bend your wrist and assist the movement with your other hand. Hold sees. 
Then straighten your wrist and assist the movement with your other hand. Hold 
sees. 
Repeat_ times. 
With your thumb touch each finger-tip. 
Repeat_ times. 
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AUNDERS' 
~CISES 
~~~XPRESST" 
D:ERCISE SOFIWARE 
© PhysioTools Ltd 
© PhysioTools Ltd 
© PhysioTools Ltd 
© Phy ;ioTools Ltd 
Built on Tools® 3.0 
Personal Exercise Program 
Provided for : Liam Johnson 3 Months 
Shoulder Flexion 
Stand facing a wall with your arms straight and hands on the wall. 
Do push-ups against the wall keeping your body in a straight line. 
Repeat_ times. 
Shoulder Extension 
Stand with your back against the wall. Keep your upper arm close to the side and 
elbow at a right angle. 
Push the elbow back against the wall. 
Repeat _times. 
Elbow Flexion 
Stand or sit with arms hanging down. Hold _ kg handweights and turn your 
palms forward. 
Bend alternate elbows briskly. 
Repeat _ times. 
Elbow Extension 
Sit or stand holding a_ kg handweight. 
Bring the arm to be exercised up with the elbow pointing to the ceiling. Support the 
elbow with the other hand. Straighten the arm holding the weight. 
Repeat'_· _times. 
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PhysioTools Ltd 
© Physic Tools Ltd 
+ 
©Physic Tools ltd 
Built on Tools® 3.0 
Upper Trunk Flexion 
Stand or sit. 
Push shoulders forward, stretch the arms diagonally forwards and down keeping 
your chin in. Hold stretching 20 sees. 
Repeat _times. 
Upper Trunk Extension 
Sit with your back straight and feet firmly on the floor. 
Pull your shoulder blades together while turning your thumbs and hands outwards. 
Repeat_ times. 
Horizontal Shoulder Abduction 
Stand sideways next to a wall. Lift your arm so that your shoulder and elbow are at 
right angles. 
Push your forearm against the wall. Hold approx. _sees . 
. Repeat_ times. 
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SAUNDERS' 
EXERCISES 
~~~XPRESS"' 
EXEROSE SOFTWARE 
© PhysioTools Lid 
© PhysioTools Ltd 
© PhysioTools Lid 
© Ph;sioTools Lid 
Built on Tools® 3.0 
Personal Exercise Program 
Hip Flexion 
Sit on the floor with one leg straight and the other bent with your arms around it. 
Try to straighten your bent leg while resisting any movement with your arms for 5 
sees. - relax. Then pull the leg closer to your i;>ody. Hold approx. 20 sees. 
Repeat_ times. 
Hip Extension 
Stand straight holding on to a chair. 
Bring your leg backwards keeping your knee straight. Do not lean forwards. 
Repeat_ times. 
Hip Abduction 
Stand straight holding on to a support. 
Lift your leg sideways and bring it back keeping your trunk straight throughout the 
exercise. 
Repeat_ times. 
Knee Extension 
Sitting with your arms crossed or using your arms to raise yourself up. 
Stand up and then sit down slowly on a chair, using your arms to decellerate your 
movement. (This can be made easier and more difficult by changing the height of 
the chair). Maintain straight back throughout 
Repeat_ times. 
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PhysioTools Ltd 
© PhysioTools Ltd 
Built on Tools® 3.0 
Knee Flexion 
Stand. Hold onto a support and bring one leg slightly backwards. 
Bend your knee and lift your foot off the floor. Hold _sees. 
Repeat _. _ times. 
Calf Raises (Using block or step) 
Place the ball of the foot on a small (5 em) block or step. Press the heel to the 
floor, keeping your legs straight. Pull your hip forwards over the toes to feel the 
stretch in the calf, then slowly raise up, then back down again. 
Hold for sees. 
Repeat __ times. 
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Appendix I 
Diary template given to each patient 
with a workbook to record training 
information and subjective feelings 
experienced by the patients' as 
requested by the investigator 
,._ 
• Date 
• Time of day 
• Duration of exercise session (minutes) 
• Exercises Performed and Quantity 
• VAS Rating upon waking 
0 Fatigue (F) 
0 Muscle soreness (MS) 
0 Breathlessness (B) 
• VAS Rating immediately post-e:-;ercise session 
0 Fatigue (F) 
0 Muscle soreness (MS) 
0 Breathlessness (B) 
'I' 
J> 
• Visual Analogue Scale (1-10 rating system) 
l=Notatall I 0 =Very much so 
• Rating of Perceived Exertion (RPE) for the exercise session (Borg 0-10 scale 
• 
to be completed 30 minutes post-exercise session) 
o 0 =Rest 
o 1 =Very, very easy 
o 2 =Easy 
o 3 = Moderate 
o 4 = Somewhat hard 
o 5 =Hard 
0 6 =-
0 7 =Very hard 
0 8 =-
0 9=-
0 I 0 =Maximal 
Falls 
o When? 
o Why? 
o Injuries sustained as a result of the fall? 
• ·Any other comments (for example: other strenuous activity undertaken, other 
health issues, general feeling ofweilbeing) 
Appendix J 
Photos of IBM.study participant 
consented by patient to be shown in 
investigators Thesis 
An IBM patient from the Australian Neuromuscular Research Institute. The photo on the right 
clearly shows the muscular atrophy that is prominent in IBM patients knee extensors. Upon 
closer inspection of this photo, scars on the knee can also be seen, which is also a common 
feature of IBM patients as a result of falls they . are pre-disposed to with the quadriceps 
weakness they are afflicted by. The two photo's on the right show the decreased joint range of 
motion these· patients have in their finger and wrist flexors and extensors. Particularly reduced 
finger flexion, and particularly the two fingers shown and their distal joints more so than the 
proximal joints. 
Appendix K 
Honours Study Budget and Timeline 
Project Budget 
1. Edith Cowan University vehicle hire to transport exercise bikes to patients homes 
-$300 
2. Transport fare for patients to attend the Centre for Neuromuscular and 
Neurological Disorders for patient assessment- $300 
Project Timeline 
Complete Thesis 
March April August September November 
AppendixL 
Table 3. Mean changes in muscle 
strength of total patient group 
' ~. 
Table.3. Total group (n=7) mean (±SE) muscle strength data pre and post exercise 
intervention, where P(T <=t) one-tail was used for any healthy/trained muscles, and 
P(T <=t) two-tail for any diseased/trained or untrained and healthy/untrained muscles. 
Muscle Mean P-value 
Pre Post * p< 0.05 
Diseased/Untrained 
Grip Strength 150.18 138.27 0.122 
Diseased/Trained 
Knee Extension 7.32 6.66 0.805 
Wrist Extension 9.87 9.08 0.271 
Healthy/Untrained 
Shoulder External Rotation 7.45 7.64 0.652 
Healthy/Trained 
Elbow Extension 7.45 6.83 0.067 
Elbow Flexion 10.92 11.05 0.402 
Shoulder Abduction 12.35 17.2 * 0.000 
Hip Flexion 11.48 15.59 * 0.008 
Hip Abduction· 9.02 10.57 * 0.041 
Knee Flexion 10.46 11.53 * 0.027 
